


















































































































































































The	 function	 of	 a	 protein	 is	 largely	 a	 consequence	 of	 its	 structure,	 with	 different	
functions	 being	 associated	 with	 particular	 three-dimensional	 folds	 in	 the	 proteins	
performing	 them.	 (Hegyi	 &	 Gerstein	 1999)	 Describing	 the	 three-dimensional	
structure	of	a	protein	from	its	amino	acid	sequence	is	not	trivial,	leading	to	a	number	
of	 techniques	 being	 developed	 over	 the	 years	 to	 obtain	 high-quality	 structural	





While	 significant	 improvements	 in	 resolution	 have	 been	 achieved	 since	 the	 first	
protein	 structures	 were	 described,	 x-ray	 crystallography	 is	 not	 without	
disadvantages:	creating	protein	crystals	for	water-insoluble	proteins	(e.g.	membrane	
proteins)	 remains	 a	 considerable	 challenge,	 and	 the	 crystallization	 process	 might	
result	in	a	loss	of	information	regarding	the	native	structure	of	the	protein.	(Yonath	









in	 solution	smaller	 than	30-40	kDa	and	requiring	 large	amounts	of	 soluble	protein,	
NMR	 has	 been	 applied	 with	 great	 success	 to	monitor	 intermolecular	 interactions,	






in	 a	 phospholipid	 bilayer.	 (Goldie	 et	 al.	 2014)	 Mass	 spectrometry	 (MS)	 has	 also	
emerged	as	a	powerful	tool	to	characterize	secondary	protein	structures:	techniques	
such	as	ion	mobility	MS	or	hydrogen/deuterium	exchange	MS	are	nowadays	able	to	
detect	 structural	 differences	 or	 probe	 protein-ligand	 interactions.	 (Chalmers	 et	 al.	







site-directed	 mutagenesis	 has	 been	 extensively	 used	 to	 study	 the	 role	 of	 specific	
protein	residues	in	protein	function,	as	the	importance	of	the	mutated	residues	can	
be	 determined	 by	 comparing	 the	 biological	 function	 of	 the	 native	 and	 mutant	
variants.	 (Morrison	 &	Weiss	 2001)	 Domain	 shuffling	 among	 related	 proteins	 with	
differing	 functions	 can	 also	 be	 very	 informative,	 as	 the	 biological	 activities	 of	 the	
chimeric	proteins	thus	created	offer	critical	 insight	into	the	structural	determinants	
influencing	protein	function.	(Lafuse	1991)	In	this	way,	studies	on	protein	structure	
and	 function	 are	 closely	 interrelated:	 the	 availability	 of	 structural	 information	
permits	 restricting	the	design	of	mutant	protein	variants	 to	putative	active	sites	or	
interacting	 regions,	 while	 the	 mutants	 thus	 created	 can	 confirm	 and	 add	 to	 the	
information	offered	by	structural	models.	(Wildhagen	et	al.	2011)	The	application	of	
these	different	methods	has	 resulted	 in	a	deeper	understanding	of	protein-protein	









in	 contrast	 to	 hormones	 cytokines	 are	 mostly	 absent	 in	 the	 circulation	 and	 their	
concentrations	 only	 increase	 drastically	 in	 response	 to	 trauma	 or	 infection;	 in	
addition,	 cytokines	 can	 be	 produced	 by	 virtually	 all	 nucleated	 cells,	 while	 classic	




structural	 elements	 in	 their	 receptors.	 (Schwartz	 et	 al.	 2016)	 One	 of	 the	 main	
cytokine	 classes	 is	 the	 interleukin-6	 (IL-6)	 family,	 named	 after	 its	 first	 identified	
member,	 IL-6:	 a	 pleiotropic	 cytokine	 acting	 via	 the	 glycoprotein	 130	 (gp130)	
receptor.	(Hirano	et	al.	1985)	(Hirano	et	al.	1986)	(Taga	et	al.	1989)	(Hibi	et	al.	1990)	
In	 the	 following	 years	 other	 cytokines	 have	 been	 added	 to	 the	 IL-6	 class,	 which	
nowadays	 comprises	 ten	 different	members:	 these	 are	 IL-6,	 interleukin-11	 (IL-11),	
interleukin-27	 (IL-27),	 interleukin-31	 (IL-31),	 leukemia	 inhibitory	 factor	 (LIF),	






The	 different	 members	 of	 the	 IL-6	 family	 present	 very	 little	 sequence	 homology,	
although	 they	 all	 adopt	 a	 common	 secondary	 structure:	 all	 of	 them	 form	 a	 four-
helical	 bundle	 with	 an	 up-up-down-down	 topology,	 linked	 by	 loops.	 (Bazan	 1990)	
(Robinson	et	al.	1994)	(McDonald	et	al.	1995)	(Somers	et	al.	1997)	(Deller	et	al.	2000)	
Besides	these	similarities	 in	their	secondary	structure,	all	of	these	cytokines	recruit	




In	 addition	 to	 gp130	 there	 are	 other	 signaling	 receptors	 interacting	 with	 the	 IL-6	
class	 ligands:	 these	 include	 the	 LIF	 receptor	 (LIFR),	 OSM	 receptor	 (OSMR),	 IL-27	




a	 LIFR/gp130	heterodimer.	 (Murakami	 et	 al.	 1993)	 (Yin	 et	 al.	 1993)	 (Gearing	 et	 al.	
1992)	 (Davis,	 Aldrich,	 Stahl,	 et	 al.	 1993)	 (Pennica	 et	 al.	 1995)	 (Elson	 et	 al.	 2000)	
(Derouet	et	al.	2004)	Additionally,	OSM	has	the	exceptional	ability	within	the	family	




In	 some	 cases	 the	 activation	 of	 these	 signaling	 receptor	 complexes	 requires	 the	
participation	of	non-signaling	 receptors,	which	 include	 the	 IL-6	 receptor	 (IL-6R)	 for	
IL-6,	 the	 IL-11	 receptor	 alpha	 (IL-11RA)	 for	 IL-11,	 the	 Epstein-Barr	 virus	 induced	 3	
(EBI3)	 for	 IL-27	and	 the	CNTF	 receptor	 (CNTFR)	 for	CNTF,	CLC	and	NP.	 (Taga	et	 al.	
1989)	 (Baumann	et	al.	1996)	 (Devergne	et	al.	1997)	 (Davis,	Aldrich,	 Ip,	et	al.	1993)	
(Elson	et	al.	2000)	(Derouet	et	al.	2004)	Although	not	directly	involved	in	intracellular	
signaling,	 the	 aforementioned	 cytokines	 are	 unable	 to	 efficiently	 recruit	 their	
signaling	receptors	unless	they	are	first	bound	to	their	non-signaling	receptor.	(Davis,	






Figure	 1:	 Cytokine-receptor	 interactions	 within	 the	 IL-6	 cytokine	 family.	 IL-6	
cytokines	signal	through	several	different	signaling	receptor	complexes:	IL-6	and	IL-
11	 employ	 a	 gp130/gp130	 homodimer,	 with	 LIF,	 CNTF,	 CLC,	 CT-1,	 NP	 and	 OSM	
binding	to	a	LIFR/gp130	heterodimer.	OSM	can	also	use	the	OSMR/gp130	complex,	
while	IL-27	utilizes	the	IL27-RA/gp130	complex	and	IL-31	binds	to	OSMR/IL-31RA.	In	








with	high	affinity	 (LIFR/gp130	and	OSMR/gp130),	 so	 it	 should	 come	as	no	 surprise	
that	this	cytokine	influences	a	wide	array	of	biological	processes.	(Thoma	et	al.	1994)	
(Hermanns	2015)	 It	 appears	 to	be	of	particular	 importance	 in	 the	 liver,	where	 the	
role	of	OSM	has	been	very	well	characterized:	one	of	its	functions	is	the	regulation	of	
cholesterol	 metabolism	 through	 the	 modulation	 of	 the	 levels	 of	 low-density	
lipoprotein	 (LDL)	 receptors	 in	 liver	 cells.	 (Grove	et	 al.	 1991)	 This	 cytokine	 can	 also	
promote	hepatocyte	proliferation	through	activation	of	the	OSMR,	a	process	that	is	





OSM	 has	 also	 been	 shown	 to	 be	 an	 important	 modulator	 of	 hematopoiesis,	
stimulating	both	 the	hematopoietic	progenitor	 cells	directly	 as	well	 as	 the	 stromal	
cells	 influencing	the	hematopoietic	microenvironment.	 (Tanaka	et	al.	2003)	Several	



































However,	 given	 that	 the	main	 sources	 of	 OSM	 in	 the	 organism	 are	 thought	 to	 be	
immune	cells	such	as	monocytes,	macrophages,	dendritic	cells	and	neutrophils,	the	
importance	 of	 this	 cytokine	 appears	 to	 be	 magnified	 in	 the	 context	 of	 different	
pathological	conditions	(Zarling	et	al.	1986)	(Malik	et	al.	1989)	(Grenier	et	al.	1999)	
(Suda	 et	 al.	 2002)	 This	 cytokine	 was	 originally	 described	 as	 an	 inhibitor	 of	
proliferation	 of	 several	 cancer	 cell	 lines,	 but	 this	 antitumorigenic	 effect	 is	 not	




Its	 influence	 in	 inflammatory	 joint	 diseases	 such	 as	 rheumatoid	 arthritis	 has	 been	
studied	in	depth:	the	evidence	collected	so	far	suggests	that	OSM	is	able	to	induce	
maximal	 responses	 to	 other	 inflammatory	 cytokines	 in	 arthritis,	 promoting	 joint	
destruction.	 (Hui	 et	 al.	 2005)	 (Richards	 2013)	 This	 proinflammatory	 effect	 is	 also	
apparent	 in	 other	 chronic	 inflammatory	 diseases,	 such	 as	 allergen-induced	 airway	






preclinical	 disease	 models:	 in	 the	 heart	 OSM	 stimulation	 leads	 to	 cardiomyocyte	
dedifferentiation	 and	 functional	 recovery	 after	 myocardial	 infarction,	 while	
OSMR/gp130	activation	 is	 crucial	 for	 the	necessary	 recruitment	of	macrophages	at	
the	site	of	infarction	that	leads	to	cardiac	healing.	(Kubin	et	al.	2011)	(Lörchner	et	al.	
2015)	Activation	of	 the	OSMR/gp130	complex	has	also	been	 linked	with	protective	







Figure	 2:	 Main	 biological	 activities	 of	 OSM.	 OSM	 influences	 a	 wide	 array	 of	
biological	processes	 in	physiological	 conditions,	particularly	 in	 the	 liver,	 the	central	
nervous	 system	 and	 the	 bone	 marrow.	 In	 addition,	 it	 can	 also	 influence	 several	
pathological	 situations,	 such	 as	 different	 chronic	 inflammatory	 diseases,	 acute	
myocardial	 injury	 and	 cancer.	 Detailed	 explanations	 of	 these	 processes	 and	























































growth	hormone	25	years	ago.	 (de	Vos	et	al.	1992)	OSM	has	 two	distinct	 receptor	
binding	sites:	site	II	is	formed	by	the	residues	in	the	middle	of	helices	A	and	C,	while	





In	order	to	 initiate	signaling	OSM	binds	first	 to	gp130	through	site	 II,	after	which	a	
second	signaling	receptor	(LIFR	or	OSMR)	is	recruited	via	site	III.	(Mosley	et	al.	1996)	
Ligand-receptor	 interaction	 through	site	 III	 in	both	LIF	and	OSM	 is	dependent	on	a	
conserved	FXXK	binding	motif	located	in	the	N-terminal	region	of	the	D-helix	of	the	
cytokines.	 (Hudson	 et	 al.	 1996)	 (Deller	 et	 al.	 2000)	 However,	 the	 key	 features	
enabling	OSM	alone	to	interact	with	the	OSMR/gp130	complex	remain	unknown	so	
far:	 the	 most	 distinctive	 structural	 feature	 of	 OSM	 is	 an	 extended	 loop	 between	
helices	 B	 and	 C,	 but	 a	 previous	 study	 found	 that	 deletions	 in	 this	 region	 did	 not	















After	 binding	 to	 the	 ligand	 the	 receptors	 within	 the	 signaling	 complex	 undergo	
conformational	 changes,	 causing	 their	 cytoplasmic	 regions	 to	 become	 closer:	 this	
allows	tyrosine	kinases	of	the	Janus	kinase	family	(JAK)	such	as	JAK1,	JAK2	and	TYK2,	
which	 are	 found	 in	 association	 with	 the	 membrane-proximal	 region	 of	 these	
receptors,	to	phosphorylate	each	other	and	initiate	signal	transduction.	(Lütticken	et	




Signal	 transducer	 and	 activator	 of	 transcription	 (STAT)	 family	 proteins	 also	 play	 a	
central	 role	 in	 IL-6	 type	 cytokine	 signaling:	 STATs	 are	 recruited	 to	 either	
phosphorylated	receptor	tyrosine	motifs	or	to	the	JAKs	and	become	phosphorylated	
themselves,	leading	to	dimer	formation	and	accumulation	in	the	cell	nucleus,	where	
they	 act	 as	 transcription	 factors	 to	modulate	 gene	 expression.	 (Shuai	 et	 al.	 1993)	
(Shuai	 et	 al.	 1994)	 Phosphorylation	 of	 STAT3	 and	 STAT1	 has	 been	 reported	 after	
receptor	 complex	 binding	 for	 all	 family	 members,	 while	 STAT5	 and	 STAT6	 are	
phosphorylated	 specifically	 by	 activation	 of	 the	 OSMR.	 (Lütticken	 et	 al.	 1994)	
(Sadowski	et	al.	1993)	(Wang	et	al.	2000)	(Fritz	et	al.	2006)	
	
Besides	 the	 JAK/STAT	 signaling	 pathway	 just	 described,	 IL-6	 type	 cytokines	 also	
initiate	other	signaling	cascades,	such	as	the	one	comprised	by	the	Ras-Raf-mitogen-
activated	protein	kinases	 (MAPKs).	 (Schiemann	et	al.	1997)	 (Hermanns	et	al.	2000)	
Among	the	MAPKs	activated	by	the	IL-6	cytokines	are	ERK1/2,	known	to	be	involved	
in	 maintenance	 of	 cell	 survival,	 but	 also	 stress-activated	 members	 of	 the	 MAPK	
family	such	as	p38	or	c-Jun	N-terminal	kinase	(JNK).	(Wang	et	al.	2000)	(Zauberman	
et	al.	1999)	The	third	main	signaling	pathway	activated	by	these	receptor	complexes	
is	 the	 one	 mediated	 by	 the	 proteins	 phosphoinositide	 3-kinase/protein	 kinase	 B	
(PI3K/Akt),	 also	 associated	 with	 cell	 survival.	 (Negoro	 et	 al.	 2001)	 Moreover,	 the	
OSMR	 exhibits	 the	 ability	 to	 signal	 through	 additional	 pathways,	 such	 as	 the	 one	
mediated	 by	 PI3K	 and	 the	 protein	 kinase	 C	 delta,	 that	 drive	 some	 of	 its	 unique	
















negative	 form	 of	 STAT3	 suppressing	 this	 process	 during	 mouse	 development.	
(Takizawa	 et	 al.	 2003)	 In	 the	 heart	 STAT3	 is	 required	 for	 cardioprotection	 against	
ischemic	 injury,	 being	 responsible	 for	 the	OSM-regulated	 secretion	 of	 chemokines	
that	leads	to	cardiac	healing	after	myocardial	infarction.	(Hilfiker-Kleiner	et	al.	2004)	
(Lörchner	 et	 al.	 2015)	 Liver	 regeneration	 after	 injury	 is	 also	 dependent	 on	 STAT3	
activation,	 and	 as	 a	 result	 is	 impaired	 in	 mice	 lacking	 the	 OSMR.	 (Li	 et	 al.	 2002)	
(Nakamura	 et	 al.	 2004)	 Moreover,	 STAT3	 is	 also	 involved	 in	 the	 progression	 of	
chronic	 inflammatory	 diseases	mediated	 by	OSM	 such	 as	 atherosclerosis,	which	 is	
alleviated	by	reduced	STAT3	levels.	(Zhang	et	al.	2017)	The	importance	of	STAT3	for	


























displays:	 as	 stated	 before,	 human	 OSM	 (hOSM)	 is	 able	 to	 activate	 both	 human	
LIFR/gp130	(hLIFR)	and	human	OSMR/gp130	(hOSMR).	 (Mosley	et	al.	1996)	On	the	
other	hand	 its	murine	ortholog	appears	to	signal	 through	the	murine	OSMR/gp130	






the	 human	 receptor	 complexes.	 (Lindberg	 et	 al.	 1998)	 (Drechsler	 et	 al.	 2012)	 The	
















Figure	 5:	OSM	displays	 species-specific	 receptor	 activation	 abilities.	 The	 receptor	








the	 full	 physiological	 response	 that	hOSM	would	have	 in	humans.	 (Drechsler	et	 al.	







and	pathological	 situations,	 as	well	 as	 its	 potential	 therapeutic	 applications.	 These	
actions	 are	 a	 consequence	 of	 OSM	 recognizing	 and	 binding	 to	 specific	 surface	
receptor	complexes,	in	particular	the	one	formed	by	OSMR	and	gp130,	which	leads	
to	 the	 initiation	 of	 downstream	 signaling	 events	 and	 subsequent	 changes	 in	 gene	
expression.	
	
However,	 despite	 its	 biological	 relevance,	 very	 little	 detailed	 knowledge	 regarding	
the	 interaction	 between	OSM	and	 its	 receptors	 is	 available	 to	 date.	 In	 contrast	 to	
other	 IL-6	family	cytokines,	no	co-crystal	structures	 involving	OSM	and	either	of	 its	
receptor	 complex	 members	 have	 been	 reported	 so	 far.	 Furthermore,	 only	 OSM	
binding	 to	gp130	has	been	examined	 in	detail	 using	molecular	biology	 techniques:	





mOSM	 is	 specific	 for	 the	 mOSMR.	 This	 is	 particularly	 concerning	 in	 view	 of	 the	








and	hLIFR	and	 the	generation	of	mutant	hOSM	variants.	 The	 second	goal	 involved	
mapping	 the	 molecular	 determinants	 responsible	 for	 the	 existing	 divergence	 in	
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Cell	 lines	 were	 cultured	 under	 37ºC	 and	 8%	 CO2	 in	 the	 recommended	 medium	
supplemented	with	10%	FBS:	A375	and	NIH3T3	cells	were	grown	in	DMEM	medium,	
HepG2	cells	in	DMEM/F12	medium,	JAR	cells	in	RPMI	1640	medium	and	FreeStyle™	




dishes	 and	 passaged	 at	 80-90%	 confluence.	 First	 the	 medium	 was	 aspirated,	 the	
plate	 was	 washed	 once	 with	 5	 mL	 of	 PBS	 buffer	 and	 5	 mL	 of	 a	 2xTrypsin-EDTA	
solution	diluted	in	PBS	was	added.	The	plate	was	incubated	for	5-10	minutes	at	37ºC	












The	 suspension	 cell	 line	 FreeStyle™	293-F	was	 grown	 in	125	or	250	mL	disposable	
cell	culture	Erlenmeyer	flasks,	employing	a	CO2-resistant	incubator	at	150-160	rpm.	
Passage	of	these	cells	was	performed	upon	reaching	a	density	of	1	to	3x106	cells/mL,	













Cell	 stimulation	was	performed	 in	6-well	 cell	 culture	plates	with	80-90%	confluent	






buffer	 and	 protein	 loading	 buffer	 (5x)	 supplemented	 with	 protease/phosphatase	
inhibitors.	After	a	brief	sonication	(6-7	pulses	of	0.5	seconds	at	20%	power	using	a	













Tris	 Protein	 Gels.	 SDS-polyacrylamide	 gel	 electrophoresis	 (SDS-PAGE)	 was	 then	
performed	in	XCell	SureLock™	Mini-Cells	with	NuPAGE™	MES	buffer.	2	µL	of	Protein	











XCell	 II™	 Blot	Modules	were	 used	 to	 transfer	 the	 proteins	 from	 SDS-PAGE	 gels	 to	
Amersham™	Protran™	0.45	µm	NC	nitrocellulose	blotting	membranes.	The	gel	was	









After	 the	2	hours	had	passed,	membranes	were	 taken	out	of	 the	blotting	modules	
and	incubated	with	RedAlert™	Western	Blot	Stain	to	verify	the	protein	transfer	had	
been	 successful.	 In	 the	 cases	 in	 which	multiplexing	 was	 necessary	 the	membrane	
was	cut	 into	different	sections,	 in	accordance	to	 the	expected	molecular	weight	of	




Membranes	were	 then	 transferred	 to	 a	 solution	 of	 5%	 skim	milk	 powder	 in	 TBS-T	
and	 incubated	at	room	temperature	(RT)	 for	1	hour,	 in	order	to	prevent	unspecific	
protein	binding	 to	 the	membrane.	Afterwards	membranes	were	washed	 five	 times	
with	 TBS-T,	waiting	 for	 5	minutes	 at	 RT	 between	 each	wash.	 The	 desired	 primary	
antibody	 was	 diluted	 following	 the	 manufacturer's	 instructions	 into	 a	 solution	 of	
	 41	




washed	 5	 times	 with	 TBS-T,	 followed	 by	 a	 1-hour	 incubation	 at	 RT	 with	 the	
corresponding	 secondary	 antibody	 in	 a	 solution	 of	 3%	 skim	milk	 powder	 in	 TBS-T.	
Removal	 of	 the	 secondary	 antibody	was	 followed	 by	 an	 additional	 5	 washes	with	
TBS-T.	Detection	was	performed	with	an	Odyssey®	9120	imaging	system	in	the	case	







using	 InstantBlue™	 Coomassie®	 stain.	 After	 protein	 separation	 by	 electrophoresis	
the	gel	cassette	was	removed,	the	gel	was	transferred	to	the	InstantBlue™	solution	




























To	 cast	 an	 agarose	 gel	 for	 DNA	 electrophoresis,	 1%	 agarose	 was	 added	 into	 TAE	
buffer	 and	 the	 mixture	 was	 heated	 in	 a	 microwave	 oven	 until	 the	 agarose	 was	
completely	dissolved.	Once	it	had	cooled	down	to	55ºC	a	small	amount	(4	µL	per	100	
mL	of	solution)	of	1%	ethidium	bromide	was	mixed	in,	and	the	resulting	solution	was	




was	 filled	with	 TAE	 buffer	 and	 the	 DNA	was	 loaded	 into	 the	wells	 along	with	 the	
appropriate	 GeneRuler	 DNA	 ladder.	 The	 chamber	 was	 then	 connected	 to	 an	
electrophoresis	power	supply,	and	electrophoresis	was	carried	out	for	20-30	minutes	





Genes	 selected	 for	 recombinant	 protein	 expression	 in	E.	 coli	were	 cloned	 into	 the	


































was	 measured	 by	 a	 NanoDrop	 2000c	 UV-Vis	 spectrophotometer,	 and	 ligation	
reactions	were	performed	with	a	3:1	molar	 ratio	between	 the	gene	 to	be	 inserted	
and	the	vector.	
	








design	 of	 the	 overlapping	 oligonucleotides	 covering	 the	 optimized	 gene	 sequence	
was	done	with	DNAWorks.	 (Hoover	&	 Lubkowski	 2002)	Default	 options	were	used	
except	 in	 two	 cases:	 the	 first	 concerned	 the	 selection	 of	 the	 option	 'no	 gaps	 in	






2009)	 In	 the	 first	 PCR	 amplification	 procedure,	 50	 µL	 of	 Phusion	 HF	 buffer	 was	
supplemented	with	2	pM	of	each	of	 the	designed	oligonucleotides,	200	µM	dNTPs	
and	 1	 unit	 of	 Phusion	 Hot	 Start	 II	 DNA	 Polymerase.	 The	 oligonucleotides	 were	































Point	mutants	were	 created	by	different	 procedures,	 including	 gene	 synthesis	 and	
overlap	extension	PCR,	but	most	of	the	variants	used	in	this	work	were	generated	by	




Full-length	 plasmid	 amplification	 was	 achieved	 by	 PCR	 reaction,	 using	 a	 25	 µL	
mixture	 containing	 PfuUltra	 buffer,	 0.25	 µM	 of	 each	 primer,	 200	 µM	 dNTPs,	 1.25	
units	of	PfuUltra	High	Fidelity	DNA	Polymerase	and	20	ng	of	template	plasmid	DNA.	
The	reaction	conditions	involved	a	first	denaturation	step	(95ºC,	1	minute)	followed	
by	30	cycles	of	denaturation	 (95ºC,	30	 seconds),	annealing	 (68ºC,	30	 seconds)	and	






After	a	15-minute	 incubation	at	RT	 the	 solution	was	centrifuged	 for	15	minutes	at	
21000	g	and	the	supernatant	was	discarded.	The	pellet	was	washed	with	500	µL	of	
70%	 ethanol	 and	 centrifuged	 again	 (10	 minutes,	 21000	 g),	 the	 supernatant	 was	




in	 order	 to	 remove	 the	original	 plasmid	 employed	 as	DNA	 template.	 Since	DpnI	 is	
only	 able	 to	 cut	methylated	DNA	 the	 template	 vector	 isolated	 from	E.	 coli	will	 be	
degraded,	while	 the	unmethylated	PCR	product	will	not	be	affected.	After	4	hours	
the	digestion	mixture	can	be	directly	used	to	transform	chemically	competent	XL-1	






broth	without	 antibiotics	was	 first	 inoculated	with	 10	µL	 of	 XL1	Blue	E.	 coli	 under	
sterile	conditions.	After	incubation	for	1	hour	at	37ºC	and	700-800	rpm,	50-100	µL	of	
the	 solution	 was	 plated	 into	 an	 LB-Agar	 plate	 without	 antibiotics	 and	 allowed	 to	
grow	overnight	in	a	bacterial	incubator	at	37ºC.	
	
The	 following	 day	 5	mL	 of	 LB	 broth	were	 inoculated	with	 a	 single	 clone	 from	 the	




















the	 sample	 was	 incubated	 for	 60-90	minutes	 at	 37ºC	 and	 700-800	 rpm.	 Bacterial	
cells	were	pelleted	by	centrifugation	for	1	minute	at	2000	g,	1	mL	of	supernatant	was	
discarded	and	the	pellet	was	resuspended	in	the	remaining	solution.	Samples	were	





Plasmid	 DNA	was	 amplified	 in	 transformed	 XL1	 Blue	 E.	 coli.	 For	 the	 isolation	 of	 a	
small	amount	of	plasmid	DNA	after	molecular	cloning	(miniprep),	3	mL	of	LB	broth	
with	 the	 adequate	 selection	 antibiotic	was	 inoculated	with	 a	 single	 colony	 from	 a	
plate	of	transformed	E.	coli	and	incubated	overnight	at	37ºC	and	180-220	rpm.	
	








the	 genomic	 DNA.	 The	 supernatant	 containing	 plasmid	 DNA	 was	 transferred	 to	
another	 tube	 containing	 500	 µL	 of	 isopropanol	 and	 subsequently	 precipitated	 by	
centrifugation	at	21000	g	and	4ºC	for	20	minutes.	After	washing	the	pellet	with	500	
µL	 of	 70%	 ethanol	 by	 centrifugation	 at	 21000	 g	 and	 4ºC	 for	 10	 minutes,	 the	
supernatant	was	decanted	and	 the	pellet	was	allowed	 to	dry	 for	10-15	minutes	 to	
remove	 residual	 ethanol.	 Finally,	 the	 pellet	was	 resuspended	 in	 TE	 buffer	 and	 the	
plasmid	 DNA	 was	 verified	 by	 DNA	 sequencing	 (performed	 by	 Seqlab	 Sequence	
Laboratories	Göttingen)	and/or	restriction	enzyme	digestion.	
	
For	 the	 isolation	 of	 large	 amounts	 of	 plasmid	 DNA	 after	 plasmid	 verification,	 the	
NucleoBond®	Xtra	Maxi	kit	was	used	according	to	the	manufacturer's	instructions.	A	
starter	culture	of	3	mL	of	LB	broth	supplemented	with	the	selection	antibiotic	was	
inoculated	with	 a	 single	 colony	 and	 grown	 for	 8	 hours	 at	 37ºC	 and	 180-220	 rpm,	

















Finally	 the	 ethanol	 was	 discarded	 and	 the	 pellet	 was	 allowed	 to	 dry	 at	 room	
temperature	 for	 15	minutes,	 before	 re-suspension	 in	 300	µL	 of	 TE	 buffer.	 Plasmid	






3	 mL	 of	 TriFast™	 was	 added	 to	 a	 10	 cm	 cell	 culture	 dish	 of	 80-90%	 confluent	
monolayer	cells,	the	cells	were	harvested	with	the	help	of	a	pipette	and	incubated	at	





was	 added	 and	 incubated	 at	 RT	 for	 10	minutes,	 after	which	 it	was	 centrifuged	 at	
12000	g	and	4ºC	for	15	minutes	to	enable	RNA	precipitation.	The	supernatant	was	





the	RNA	was	ensured	by	an	 incubation	at	56ºC	and	850	 rpm	 for	10	minutes,	after	



















Immediately	after	 this	step	1	µL	of	Superscript®	 II	 reverse	transcriptase	was	added	
and	the	mixture	was	incubated	at	25ºC	for	an	additional	10	minutes,	followed	by	an	
incubation	at	42ºC	for	50	minutes	and	a	final	 incubation	at	70ºC	for	15	minutes	to	













the	 following	 day	 the	 starter	 culture	 was	 diluted	 into	 200	 mL	 of	 LB	 broth	 with	
kanamycin,	 and	 the	 resulting	 solution	 incubated	 at	 30ºC	 and	 180-220	 rpm	 until	
reaching	an	OD600	value	of	0.5-0.7.	
	
At	 this	 point	 the	 culture	 was	 supplemented	 with	 0.1	 mM	 of	 IPTG	 to	 induce	
recombinant	 protein	 expression	 and	 allowed	 to	 grow	 for	 an	 additional	 4-6	 hours.	
Finally,	the	bacterial	cells	were	harvested	by	centrifugation	at	5000	g	and	4ºC	for	10-













21000	 g	 and	 4ºC	 for	 30-40	 minutes	 to	 separate	 the	 insoluble	 fraction.	 The	












0.6	mL	 of	OptiPro™	 SFM	kept	 at	 RT	 in	 a	 sterile	 tube	 and	mixed	 by	 inversion.	 In	 a	
second	 tube	 37.5	 µL	 of	 FreeStyle™	 MAX	 Reagent	 was	 also	 diluted	 in	 0.6	 mL	 of	
OptiPro™	SFM	at	RT	and	mixed	by	inversion.	
	
Immediately	 afterwards	 the	 OptiPro™	 SFM	 medium	 with	 the	 MAX	 reagent	 was	






4ºC	 for	15	minutes	 to	pellet	cells	and	 insoluble	debris.	The	supernatant	containing	






All	 purification	 steps	 were	 performed	 at	 4ºC.	 0.75-1	 mL	 of	 HIS-Select®	 HF	 nickel	
affinity	gel	slurry,	containing	nickel-nitrilotriacetic	acid	(Ni-NTA)	chelate	groups	able	






The	 column	 was	 then	 capped	 and	 supernatant	 containing	 C-terminal	 his-tagged	






gravity	 flow,	 followed	 by	 washing	 with	 10	 column	 volumes	 of	 His-tag	 purification	
wash	buffer.	To	elute	the	recombinant	protein	from	the	affinity	gel,	the	column	was	
capped	 and	 1	 mL	 of	 His-tag	 purification	 elution	 buffer	 added.	 After	 a	 10-minute	
incubation	 the	 cap	was	 removed,	 the	 buffer	 collected	 and	 the	 elution	 repeated	 3	
additional	times.	
	
Finally,	 the	 eluted	 product	 was	 concentrated	 in	 centrifugal	 filters	 with	 a	 10	 kDa	










Immediately	 after	 this	 step,	 2.5x105	 cells	 resuspended	 in	 2.5	mL	 of	 antibiotic-free	
growth	medium	supplemented	with	10%	FCS	were	added	to	each	well	and	incubated	
overnight	under	37ºC	and	5-8%	CO2	 conditions.	On	 the	 following	day	 the	medium	
was	exchanged	to	growth	medium	with	antibiotics	and	FCS,	and	cells	were	allowed	





Deglycosylation	 assays	 were	 performed	 using	 the	 Protein	 Deglycosylation	 Mix	 kit	
under	 denaturing	 reaction	 conditions.	 18	 µL	 of	 recombinant	 protein	 in	 PBS	 was	





5	 µL	 of	 glycobuffer	 2,	 5	 µL	 of	 10%	 NP-40	 and	 15	 µL	 of	 distilled	 water	 were	 then	









significant.	 Welch's	 T-test	 is	 a	 variant	 of	 Student's	 T-test	 recommended	 for	 small	
sample	 sizes	 and/or	 unequal	 group	 variances;	 as	 is	 the	 case	 for	 other	 parametric	
















aligned	 protein	 sequences	 were	 then	 used	 to	 construct	 a	 phylogenetic	 tree	 by	
stochastic	 heuristics,	 applying	 the	 metapopulation	 genetic	 algorithm	 (metaGA)	











The	 first	 step	 in	 order	 to	 study	 receptor	 complex	 activation	 required	 establishing	
reliable	systems	to	monitor	this	event.	Unfortunately,	there	are	no	tools	available	to	









Different	 human	 cell	 lines	 have	 been	 identified	 that	 exclusively	 express	 either	 the	
OSMR/gp130	complex	(A375	human	melanoma	cell	 line,	Fig.	6A)	or	the	LIFR/gp130	
complex	 (JAR	 human	 choriocarcinoma	 cell	 line,	 Fig.	 6C).	 (Auguste	 et	 al.	 1997)	 By	
performing	cytokine	stimulations	 in	parallel	 in	 two	such	cell	 lines,	 it	becomes	 then	
possible	to	assess	the	activation	of	each	of	the	receptors	through	the	comparison	of	
the	 STAT3	 phosphorylation	 pattern	 10	 minutes	 after	 stimulation.	 (Chollangi	 et	 al.	
2012)	
	
To	 further	 validate	 this	 readout	 system,	 siRNA	 experiments	 were	 performed	 to	
confirm	 that	 the	 observed	 STAT3	 phosphorylation	 in	 A375	 and	 JAR	 cell	 lines	 is	 a	









activation	 in	 JAR	 cells.	 (A)	STAT3	phosphorylation	pattern	 in	A375	cells	stimulated	
for	10	minutes	with	hLIF	and	hOSM.	(B)	STAT3	phosphorylation	pattern	in	A375	cells	
treated	for	72	hours	with	the	indicated	siRNAs,	and	stimulated	for	10	minutes	before	
sample	 harvesting.	 (C)	 STAT3	 phosphorylation	 in	 JAR	 cells	 after	 a	 10-minute	
stimulation	with	hLIF	and	hOSM.	 (D)	 STAT3	phosphorylation	 in	 JAR	cells	 incubated	




To	 corroborate	 that	 the	 variations	 potentially	 observed	 in	 STAT3	 phosphorylation	
are	not	 just	due	 to	a	delay	 in	 signaling,	but	a	consequence	of	differential	 receptor	
activation	 properties,	 a	 second	 readout	 system	 based	 on	 longer-term	 (24	 hour)	
stimulation	 experiments	 was	 established.	 Tissue	 inhibitor	 of	 metalloproteinase	 1	
(TIMP1)	 upregulation	 is	 a	 well-known	 target	 of	 OSMR	 activation	 in	 different	 cell	
types,	including	hepatic	cells,	so	the	HepG2	human	hepatoma	cell	line	was	selected	
to	monitor	 hOSMR	 activation	 through	 TIMP1	 expression	 (Fig.	 7A).	 (Richards	 et	 al.	




















































Figure	 7:	 TIMP1	 expression	 after	 24	 hours	 reflects	 hOSMR	 activation	 in	 HepG2	
cells,	while	 STAT3	upregulation	 is	 a	 consequence	of	hLIFR	activation	 in	 JAR	 cells.	
(A)	 TIMP1	 expression	 levels	 in	 HepG2	 cells	 stimulated	 for	 24	 hours	with	 hLIF	 and	
hOSM.	 (B)	TIMP1	expression	in	HepG2	cells	treated	for	48	hours	with	the	indicated	
siRNAs,	 and	 subsequently	 stimulated	 for	 an	 additional	 24	 hours	 before	 sample	
harvesting.	 (C)	Total	STAT3	 levels	 in	 JAR	cells	after	a	24-hour	stimulation	with	hLIF	
and	hOSM.	(D)	Total	STAT3	expression	levels	in	JAR	cells	incubated	for	48	hours	after	




In	 addition,	 a	 non-Western	 blot	 based	 assay	 system	was	 implemented	 to	 confirm	
long-term	biological	activity	caused	by	hOSMR	activation.	OSM	was	first	described	as	
a	 growth	 regulator	 of	 human	 tumor	 cells,	 inhibiting	 the	 proliferation	 of	 A375	
melanoma	 cells	 as	well	 as	 other	 tumor-derived	 cell	 lines.	 (Zarling	 et	 al.	 1986)	 This	





a	 colorimetric	assay	employed	 to	detect	 living	cells.	 (Mosmann	1983)	By	means	of	















































was	amplified	by	PCR	and	 cloned	 in	 a	pET-26b(+)	 vector.	 This	 vector	 contains	 a	C-
terminal	His-tag	and	a	T7	promoter,	which	enables	recombinant	protein	expression	






little	 soluble	protein	 could	be	detected	2	hours	after	 IPTG	 induction	 (Fig.	9A).	This	
particularity	had	 forced	past	 studies	on	OSM	and	mutant	OSM	variants	 to	 apply	 a	
variety	of	strategies	to	obtain	these	recombinant	proteins	in	soluble	form.	Successful	
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Since	most	of	 these	approaches	require	additional	 time-consuming	steps,	an	effort	
to	 establish	 a	 protocol	 for	 production	 of	 soluble	 hOSM	 in	 E.	 coli	 was	 made	 to	
facilitate	the	generation	of	the	cytokine	variants	to	be	studied	in	this	project.	Given	
that	 disulfide	 bonds	 had	 been	 shown	 to	 be	 critical	 for	 proper	 OSM	 folding	 and	
function,	(Kallestad	et	al.	1991)	it	appeared	likely	that	OSM	aggregation	might	be	a	
consequence	 of	 the	 reducing	 redox	 state	 of	 the	 prokaryotic	 cytoplasm	 preventing	
disulfide	bond	formation.	(Baneyx	&	Mujacic	2004)	
	









Figure	 9:	 The	 presence	 of	 DsbC,	 a	 chaperone/disulfide	 bond	 isomerase,	 enables	
soluble	 recombinant	 hOSM	 expression	 in	 E.	 coli.	 Western	 blots	 using	 penta-His	
antibody	 to	 detect	 recombinant	 His-tagged	 hOSM	 production	 are	 shown.	 (A)	
Expression	of	hOSM	in	BL21	(DE3)	E.	coli	2	hours	after	induction	with	0.5	mM	IPTG	at	
different	 temperatures	and	densities,	 as	measured	by	OD600.	 The	 soluble	 (Sol)	 and	
insoluble	 (Pell)	 protein	 fractions	 are	 compared,	 with	 very	 little	 soluble	 OSM	 in	
evidence.	 (B)	 Expression	 of	 hOSM	 in	 SHuffle®	 T7	 Express	 E.	 coli	 at	 30ºC	 after	





for	 purification	 of	 the	 recombinant	 protein	 out	 of	 the	 bacterial	 cell	 lysate.	 The	
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inclusion	 of	 a	 C-terminal	 His-tag	 greatly	 facilitated	 this	 task,	 enabling	most	 of	 the	
bacterial	 contaminants	 to	 be	washed	 away	out	 of	 a	Ni-NTA	 affinity	 gel	 column	by	





Figure	 10:	 Effective	 recovery	 of	 recombinant	 His-tagged	 hOSM	 by	 Ni-NTA	
purification.	(A)	Silver	staining	reveals	most	of	the	bacterial	proteins	 in	the	soluble	
fraction	 are	 eliminated	 during	 the	 purification	 procedure.	 Strong	 bands	 at	
approximately	 24	 kDa	 in	 the	 first	 three	 elution	 steps	 correspond	 to	 the	 eluted	
recombinant	 hOSM.	 (B)	 Western	 blotting	 of	 the	 same	 samples	 using	 penta-His	







the	 solution.	 This	 led	 to	 a	 recombinant	 protein	 solution	 comparable	 to	 the	










h Wash  
(mM Imidazole) 
10 30 40 20 50 
Elution 
(mM Imidazole) 







h Wash  
(mM Imidazole) 
10 30 40 20 50 
Elution 
(mM Imidazole) 



















15	minutes	 (Fig.	 12A)	 and	 24	 hours	 (Fig.	 12B).	 Phosphorylation	 patterns	 of	 known	
downstream	mediators	of	OSMR	activation	after	10	minutes	were	identical	for	both	



















































































































the	 commercially	 available	 cytokine.	 (A)	 Western	 blots	 of	 HepG2	 cell	 samples	
harvested	 after	 a	 10-minute	 stimulation	 with	 20	 ng/mL	 of	 the	 cytokines	 show	
comparable	phosphorylation	patterns	for	commercial	and	His-tag	purified	hOSM.	(B)	










cloned	 into	 three	different	mammalian	expression	vectors	 (pcDNA™	3.1(+),	pFLAG-
CMV-3	 and	 pCAGGS),	 preceded	 by	 a	 Kozak	 consensus	 sequence	 and	 either	 their	




to	 the	 manufacturer's	 instructions.	 A	 comparison	 of	 the	 expression	 levels	 3	 days	
after	 transfection	 showed	 robust	 secretion	 of	 recombinant	 hOSM	 in	 the	
supernatant,	but	much	lower	production	of	human	LIF	(Fig.	13A).	Since	the	pCAGGS	
plasmid	 with	 native	 signal	 peptide	 evidenced	 the	 highest	 level	 of	 expression	 for	
hOSM,	constructs	using	this	plasmid	were	employed	for	all	further	experiments.	
	
A	 deglycosylation	 test	 confirmed	 that	 the	 apparent	 smearing	 and	 differences	 in	
molecular	 weight	 in	 comparison	 to	 the	 bacterial-derived	 cytokines	 are	 caused	 by	
glycosylation,	 a	 post-translational	 modification	 exclusive	 of	 eukaryotic	 cells	 (Fig.	
13B).	These	initial	tests	were	followed	by	the	assessment	of	the	expression	over	time	
for	 both	 cytokines,	 in	 order	 to	 determine	 the	 optimal	 incubation	 time	 after	
transfection.	 While	 hOSM	 expression	 reached	 maximum	 levels	 as	 little	 as	 3	 days	







Western	 blot	 of	 FreeStyle™	 293-F	 cell	 medium	 3	 days	 after	 transfection	 with	 the	
indicated	 vectors,	 using	 penta-His	 antibody	 to	 detect	 recombinant	 protein	
expression,	 reveals	 strong	expression	of	hOSM	cloned	 into	 the	PCAGGS	vector.	 (B)	
Western	 blot	 of	 untreated	 (-)	 and	 deglycosylated	 (+)	mammalian-derived	 hLIF	 and	
hOSM	 after	 purification	 demonstrates	 the	 occurrence	 of	 post-translational	
modifications.	 (C)	Western	 blot	 of	 FreeStyle™	 293-F	 cell	medium	 collected	 3	 to	 9	
days	 after	 transfection	 with	 either	 hOSM	 or	 hLIF	 in	 the	 pCAGGS	 vector	 indicates	
different	peak	production	times	for	each	cytokine.	
	
Despite	 the	 additional	 post-translational	modifications,	 cytokines	 produced	 in	 this	
way	 evidenced	 equivalent	 biological	 activity	 when	 compared	 to	 commercial	
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Figure	 14:	 Recombinant	 protein	 expression	 in	 mammalian	 cells	 results	 in	 highly	
pure,	 active	 cytokines.	 (A)	Western	blot	of	A375	cell	 samples	collected	after	a	10-
minute	 stimulation	with	 hOSM	 shows	 similar	 biological	 activity	 between	 bacterial-
derived	(commercial)	and	mammalian-derived	cytokines.	(B)	Western	blot	of	JAR	cell	
samples	 subjected	 to	 a	 10-minute	 stimulation	 with	 hLIF	 evidences	 comparable	
biological	 activity	 for	 bacterial-derived	 (commercial)	 and	 mammalian-derived	




4.1.3.	 Human	 Oncostatin	 M-based	 chimeric	 proteins	 identify	 a	 critical	 binding	
region	for	human	receptor	complex	activation	
	
Despite	 the	 fact	 that	 binding	 site	 III	 of	 hOSM	 is	 a	 relatively	 large	 region	 of	 the	




and	 corresponds	 to	 phenylalanine	 160	 (F160)	 and	 lysine	 163	 (K163)	 in	 hOSM,	 is	
critical	 for	both	LIFR	and	OSMR	activation.	(Hudson	et	al.	1996)	(Deller	et	al.	2000)	


































ability	 of	 hOSM	 to	 activate	 the	 hOSMR/gp130	 complex.	 To	 this	 end	 chimeric	
cytokines	 combining	different	 regions	of	 hOSM	and	hLIF	were	designed	 (Fig.	 15C),	





Figure	 15:	 Design	 of	 human	 OSM/LIF	 chimeric	 cytokines.	 (A)	 Three-dimensional	
model	of	human	OSM.	The	N-terminal	AB	loop	region	is	shown	in	yellow,	the	BC	loop	
in	 purple	 and	 the	 N-terminal	 D-helix	 in	 green.	 (B)	 Alignment	 of	 mature	 hLIF	 and	
hOSM	amino	acid	sequences	with	Clustal	Omega.	Residues	forming	binding	site	III	of	
hOSM,	corresponding	to	the	N-terminal	AB	loop,	the	BC	loop	and	the	N-terminal	part	
of	helix	D,	 are	highlighted.	Asterisks	 (*)	denote	 fully	 conserved	 residues,	 colons	 (:)	
indicate	groups	with	strongly	similar	properties	and	periods	 (.)	are	used	for	groups	
with	 weakly	 similar	 properties.	 (C)	 Schematic	 representation	 of	 the	 constructed	











Helix A AB loop Helix B BC loop Helix C Helix D CD loop C	
A
hLIF      SPLPITPVNATCAIRHPCHNN---LMNQIRSQLAQLNGSANALFI
hOSM      ------------AAIGSCSKEYRVLLGQLQKQTD-LMQDTSRLLD
                      *    * ::   *: *::.*   *  .:. *: 
hLIF      LYYTAQGEPFPNNLDKLCGPNVTDFPPFHAN-GTEKAKLVELYRI
hOSM      PYIRIQGLDVPK-LREHCRERPGAFPSEETLRGLGRRGFLQ—TL
           *   **  .*: * : *  .   **  .:  *  :  :::   : 
hLIF      VVYLGTSLGNITRD-QK-----ILNPSALSL--HSKLNATADILR
hOSM      NATLGCVLHRLADLEQRLPKAQDLERSGLNIEDLEKLQMARPNIL
           . **  * .::   *:      *: *.*.:   .**: :   : 
hLIF      GLLSNVLCRLCSK--------YHVGHVDVTYGPDTSGKDVFQKKK
hOSM      GLRNNIYCMAQLLDNSDTAEPTKAGRGASQPPTPTPASDAFQRKL
          ** .*: *              :.*:        * ..*.**:* 
hLIF      LGCQLLGKYKQIIAVLAQAF-----------
hOSM      EGCRFLHGYHRFMHSVGRVFSKWGESPNRSR
           **::*  *::::  :.:.* 
B	
N-terminal AB loop 
BC loop 




termed	 AB1,	 involved	 the	 substitution	 of	 the	 region	 between	 residues	 proline	 33	
(P33)	to	histidine	48	(H48)	of	hOSM	by	residues	leucine	43	(L43)	to	leucine	59	(L59)	
of	hLIF,	or	vice	versa.	For	the	shorter	AB2	chimeras	the	replaced	region	started	with	
arginine	36	 (R36)	 in	hOSM	and	 threonine	46	 (T46)	 in	hLIF,	while	 the	AB3	chimeras	
started	 at	 leucine	 40	 (L40)	 of	 hOSM	and	 the	 glutamic	 acid	 at	 position	 50	 (E50)	 of	
hLIF.	
	
A	 single	 replacement	 length	was	 chosen	 for	 both	 the	BC	 loop	 chimera	 and	 the	N-






After	 expression	 and	 purification	 of	 these	 variants	 in	 a	 mammalian	 expression	
system,	 the	 impact	 of	 the	 different	 binding	 site	 III	 regions	 in	 receptor	 activation	










Conversely,	 stimulation	 of	 the	 hOSMR-deficient	 JAR	 cells	 showed	 normal	 STAT3	
phosphorylation	 patterns	 for	 every	 variant	 except	 for	 the	 AB1	 chimera,	 indicating	
that	 the	secondary	 structure	of	 the	chimeras	 remains	 stable.	This	observation	also	









different	 hOSM-based	 chimeric	 cytokines	 created.	 STAT3	 phosphorylation	 reflects	
hOSMR	 activation,	 while	 total	 STAT3	 and	 pan-Actin	 serve	 as	 loading	 controls.	 (B)	
Western	blot	of	JAR	cell	samples	after	a	10-minute	stimulation	with	25	ng/mL	of	the	
indicated	 cytokines.	 STAT3	 phosphorylation	 reflects	 hLIFR	 activation,	 while	 total	
STAT3	and	pan-Actin	 serve	as	 loading	controls.	 (C)	Quantitative	analysis	of	hOSMR	
and	 hLIFR	 activation	 levels	 after	 a	 10-minute	 stimulation	 treatment	 with	 the	










or	hLIF	 (Fig.	17B-C).	The	differing	biological	activity	of	 the	AB	 loop	hOSM	chimeras	
was	further	proved	by	a	5-day	proliferation	assay.	While	WT	hOSM	and	the	BC	loop	
and	N-terminal	D-helix	chimeras	proved	able	to	activate	the	hOSMR	and	thus	inhibit	














































































HepG2	 cell	 samples	 after	 a	 24-hour	 stimulation	 with	 25	 ng/mL	 of	 the	 specified	
cytokines.	TIMP1	expression	reflects	hOSMR	activation,	while	pan-Actin	levels	serve	
as	 loading	control.	(B)	Western	blot	of	JAR	cell	samples	after	a	24-hour	stimulation	
with	 25	 ng/mL	 of	 WT	 hOSM,	 WT	 hLIF	 and	 the	 different	 hOSM-based	 chimeric	
cytokines	created.	Total	STAT3	levels	reflect	hLIFR	activation,	while	pan-Actin	serves	
as	 loading	 control.	 (C)	Quantitative	 analysis	 of	 hOSMR	 and	 hLIFR	 activation	 levels	
after	 a	 10-minute	 stimulation	 treatment	 with	 the	 indicated	 chimeric	 cytokines,	
relative	 to	 the	 observed	 activation	 for	WT	 hOSM.	Values	were	 normalized	 against	
pan-Actin	levels	and	presented	as	mean	±	s.e.m.	(n=5).	(D)	A375	proliferation	levels	
after	 a	 5-day	 stimulation	 treatment	 with	 10	 ng/mL	 of	 the	 indicated	 chimeric	
cytokines,	relative	to	the	proliferation	of	the	control	group.	Values	are	given	as	mean	
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4.1.4.	 Leukemia	 Inhibitory	 Factor-based	 chimeric	 proteins	 acquire	 the	 ability	 to	
activate	the	human	Oncostatin	M	Receptor	
	
These	 experiments	 indicate	 that	 the	 amino	 acid	 sequence	 of	 the	 AB	 loop	 within	
binding	site	III	of	hOSM	is	key	to	explain	its	unique	receptor	activation	profile	within	
the	 IL-6	 cytokine	 family.	 However,	 they	 did	 not	 rule	 out	 the	 existence	 of	 other	
differentiating	 features	 outside	 site	 III	 that	 may	 also	 be	 required	 for	 hOSMR	
activation.	To	address	this	question	a	number	of	hLIF-based	chimeric	cytokines	with	
different	regions	of	site	III	replaced	by	their	hOSM	equivalents	were	created:	these	













through	 the	 comparison	 of	 STAT3	 phosphorylation	 levels	 after	 a	 10-minute	
stimulation.	All	the	chimeras	were	still	able	to	signal	through	the	hLIFR,	but	replacing	
the	 N-terminal	 region	 of	 the	 AB	 loop	 alone	 was	 not	 enough	 for	 the	 hLIF-based	
chimera	 to	activate	 the	hOSMR.	On	 the	other	hand,	 the	combined	 replacement	of	





















different	 hLIF-based	 chimeric	 cytokines.	 STAT3	 phosphorylation	 reflects	 hOSMR	
activation,	with	 total	STAT3	and	pan-Actin	serving	as	 loading	controls.	 (B)	Western	
blot	of	JAR	cell	samples	stimulated	for	10	minutes	with	25	ng/mL	of	WT	hOSM,	WT	
hLIF	and	the	indicated	hLIF-based	chimeras.	STAT3	phosphorylation	is	an	indication	
of	 hLIFR	 activation,	while	 total	 STAT3	 and	 pan-Actin	 serve	 as	 loading	 controls.	 (C)	



























































































20A-C).	 Additional	 evidence	 that	 the	 differential	 structural	 features	 leading	 to	
hOSMR	 specificity	 are	 contained	 within	 site	 III	 of	 hOSM	 could	 be	 provided	 by	 a	





































































































































Figure	 20:	 Long-term	 receptor	 activation	 ability	 of	 hLIF-based	 chimeric	 cytokines	
confirms	 the	 importance	 of	 binding	 site	 III	 region	 for	 hOSMR	 interaction.	 (A)	






levels	 for	 the	 different	 cytokines	 tested,	 relative	 to	 WT	 hOSM.	 Values	 were	
normalized	against	pan-Actin	levels	and	presented	as	mean	±	s.e.m.	(n=5).	(D)	A375	
proliferation	 levels	 after	 stimulation	 for	 5	 days	 with	 10	 ng/mL	 of	 the	 indicated	









and	 the	N-terminal	 helix	 D	 regions	 of	 hOSM	 in	 receptor	 activation,	 point	mutants	











and	 cysteine	 49	 (C49)	were	 assessed	 for	 their	 short-term	 hOSMR/hLIFR	 activation	
ability	(Fig	21A-B).	Several	of	these	residues	specifically	abrogated	hOSMR	activation,	
including	 glutamine	 38	 (Q38),	 glycine	 39	 (G39),	 leucine	 45	 (L45)	 and	 to	 a	 lesser	








stimulation	 of	 A375	 cells	 with	 25	 ng/mL	 of	 WT	 hOSM	 and	 the	 indicated	 point	
mutants.	STAT3	phosphorylation	was	used	to	monitor	hOSMR	activation,	with	total	
STAT3	and	pan-Actin	serving	as	loading	controls.	(B)	Western	blot	of	JAR	cell	samples	
stimulated	 for	 10	minutes	with	 25	 ng/mL	 of	WT	 hOSM	 and	 the	 different	 AB	 loop	
point	mutants	shown.	STAT3	phosphorylation	measures	hLIFR	activation,	while	total	
STAT3	 and	 pan-Actin	 are	 included	 as	 loading	 controls.	 (C)	Quantitative	 analysis	 of	
hOSMR	and	hLIFR	activation	levels	for	the	different	point	mutants	tested,	relative	to	





The	crucial	 role	of	 these	 residues	 in	 receptor	activation	was	confirmed	by	24-hour	
stimulation	 experiments	 (Fig.	 22A-C),	 with	 the	 detailed	 amino	 acid	 replacements	
displaying	the	same	effects	observed	after	10	minutes	except	for	V42.	These	results	
were	 further	 reinforced	 by	 a	 5-day	 cell	 proliferation	 assay	 on	 A375	 cells.	 In	
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identified	 as	 playing	 an	 important	 role	 in	 the	 interaction	 between	 hOSM	 and	 the	





Figure	 22:	 Long-term	 receptor	 activation	 ability	 of	 human	 OSM	 AB	 loop	 point	
mutants	validates	critical	cytokine	residues.	(A)	Western	blot	of	HepG2	cell	samples	
stimulated	 for	 24	hours	with	25	ng/mL	of	WT	human	OSM	and	 the	detailed	point	
mutants.	TIMP1	expression	reflects	human	OSMR	activation,	with	pan-Actin	serving	
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stimulation	 with	 25	 ng/mL	 of	 WT	 human	 OSM	 and	 the	 different	 AB	 loop	 point	
mutants	 indicated.	 STAT3	 phosphorylation	 measures	 human	 LIFR	 activation,	 with	




10	ng/mL	of	 the	 indicated	point	mutants,	 relative	to	the	proliferation	observed	for	












residues	 to	 Y34,	 Q38,	 G39,	 L40	 and	 L45	 in	 human	 OSM	 are	 present	 in	 most	
mammalian	OSM	orthologs	compared,	with	the	exception	of	G39	in	mouse	and	rat	





was	 necessary	 before	 the	 hLIF-based	 chimera	 was	 able	 to	 activate	 the	 hOSMR,	
alanine	 scanning	 of	 this	 region	 was	 also	 performed.	 As	 expected	 the	 two	 critical	
residues	forming	the	conserved	FXXK	motif,	phenylalanine	160	(F160)	and	lysine	163	
(K163),	 proved	 to	 be	 crucial	 for	 activating	 both	 hOSMR	 and	 hLIFR	 in	 a	 10-minute	
stimulation	 assay.	 Additionally,	 substitution	 of	 the	 proline	 at	 the	 start	 of	 the	 helix	
(P153)	specifically	impaired	hOSMR	activation	(Fig.	24A-C).	
	
Mus.musculus     54   PYIRLQNLNTPDLRAAC   70
Rattus.norvegicus 55   PYILHQNLNTLTLRAAC   71
Homo.sapiens     57   PYIRIQGLDVPKLREHC   73
Pan.troglodytes 57   PYIRIQGLDVPKLREHC   73
Gorilla.gorilla  57   PYIRIQGLDVPKLREHC   73
Macaca.mulatta       57   PYIRIQGLDIPKLREHC   73
Bos.taurus       54   PYIHLQGLHSPVLQEHC   70
Capra.hircus     54   PYIRFQGLESPKLQEHC   70
Ovis.aries       54   PYIRFQGLESPKLQEHC   70
Sus.scrofa       54   PYIRMQGLDTPGLKEHC   70
Canis.lupus      54   LYIRSQGLDKNGLKEHC   70
Felis.catus      54   PYISIQGLDKDGLKEHC   70





mutants	 assesses	 individual	 residue	 involvement.	 (A)	Western	 blot	 of	 A375	 cell	
samples	collected	after	a	10-minute	stimulation	with	25	ng/mL	of	WT	hOSM	and	the	
different	 helix	 D	 point	 mutants.	 STAT3	 phosphorylation	 is	 a	 sign	 of	 hOSMR	
activation,	with	 total	STAT3	and	pan-Actin	serving	as	 loading	controls.	 (B)	Western	
blot	of	JAR	cell	samples	harvested	after	stimulation	for	10	minutes	with	25	ng/mL	of	
WT	hOSM	and	 the	helix	D	point	mutants	 shown.	STAT3	phosphorylation	measures	
hLIFR	activation,	while	 total	 STAT3	and	pan-Actin	 are	 included	as	 loading	 controls.	
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24-hour	 stimulation	 experiments	 confirmed	 the	 specific	 importance	 of	 P154	 for	
hOSMR	 activation,	 with	 the	 alanine	 mutant	 showing	 normal	 hLIFR	 activation	 but	
impaired	hOSMR-dependent	activity	 (Fig.	25A-C).	Final	proof	of	the	requirement	of	
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after	 a	 24-hour	 stimulation	 with	 25	 ng/mL	 of	 WT	 hOSM	 and	 the	 D-helix	 point	
mutants	 indicated.	 Increased	 STAT3	 levels	 are	 a	 consequence	 of	 hLIFR	 activation,	
while	pan-Actin	is	used	as	a	loading	control.	(C)	Quantitative	analysis	of	hOSMR	and	
hLIFR	 activation	 levels	 relative	 to	WT	hOSM.	Values	were	 normalized	 against	 pan-
Actin	levels	and	presented	as	mean	±	s.e.m.	(n=5).	(D)	A375	proliferation	levels	were	
assessed	 by	 an	MTT	 assay	 after	 5-day	 stimulation	with	 10	 ng/mL	 of	 the	 indicated	
cytokines,	relative	to	the	proliferation	observed	for	the	unstimulated	control	group.	
Values	are	presented	as	mean	±	s.e.m.	(n=3).	Statistical	significance	was	determined	









Besides	 the	unique	OSMR/gp130	activation	ability	explored	 in	 the	 first	part	of	 this	















protein	 sequence	 contained	 in	 the	 RefSeq	 database	 confirms	 the	 evolutionary	




































































Perhaps	 as	 a	 result	 of	 this	 evolutionary	 process,	 the	 murine	 protein	 is	 unable	 to	
activate	 any	 of	 the	 human	 receptor	 complexes	 and	 appears	 to	 act	 specifically	




Despite	 this	marked	difference	 in	 their	 receptor	activation	abilities,	both	cytokines	
are	 surprisingly	 similar	 in	 terms	 of	 amino	 acid	 composition:	 when	 the	 mature	
sequences	of	hOSM	and	mOSM	were	aligned,	48.89%	of	their	residues	turned	out	to	




This	 fact	 suggests	 that	 the	 differing	 specificity	 between	 human	 and	 mouse	 OSM	
might	 be	 explained	 by	 just	 a	 small	 number	 of	 variations,	 possibly	 in	 the	 regions	
required	for	hOSMR	interaction	identified	in	the	first	section	of	this	work.	In	order	to	
test	this	hypothesis,	chimeric	proteins	based	on	mOSM	were	designed	in	which	the	
two	main	 regions	 influencing	OSMR	binding	within	 site	 III,	 the	AB	 loop	and	 the	N-
terminal	D-helix,	had	been	replaced	by	their	hOSM	counterparts	(Fig.	27A-C).	
	
In	 this	 occasion	 two	 different	 replacement	 lengths	 were	 selected	 for	 both	 the	 N-
terminal	 AB	 loop	 and	 the	 N-terminal	 helix	 D	 constructs.	 In	 the	 shortest	 AB	 loop	





For	 the	 N-terminal	 helix	 D	 chimeras,	 the	 shortest	 modification	 (chimera	 D1)	
consisted	 of	 residues	 threonine	 142	 (T142)	 to	 serine	 152	 (S152)	 of	 mOSM	 being	
replaced	 by	 residues	 alanine	 156	 (A156)	 to	 glycine	 166	 (G166)	 of	 hOSM.	 In	 the	









N-terminal	 D-helix	 is	 shown	 in	 green.	 (B)	Alignment	 of	mature	mouse	 and	 human	
OSM	amino	acid	sequences	with	Clustal	Omega.	Residues	forming	binding	site	III	of	
OSM,	corresponding	 to	 the	N-terminal	AB	 loop	and	 the	N-terminal	part	of	helix	D,	
are	 highlighted.	 Asterisks	 (*)	 denote	 fully	 conserved	 residues,	 colons	 (:)	 indicate	










from	 NIH3T3	 cDNA	 into	 pcDNA™	 3.1(+),	 pFLAG-CMV-3	 and	 pCAGGS	 mammalian	









Helix A AB loop Helix B BC loop Helix C Helix D CD loop C	
A
mOSM      --NRGCSNSSSQLLSQLQNQANLTGNTESLLEPYIRLQNLNTPDL
hOSM      AAIGSCSKEYRVLLGQLQKQTDLMQDTSRLLDPYIRIQGLDVPKL
              .**:.   **.***:*::*  :*. **:****:* *:.*.*
mOSM      RAACTQHSVAFPSEDTLRQLSKPHFLSTVYTTLDRVLYQLDALRQ
hOSM      REHCRERPGAFPSEETLRGLGRRGFLQTLNATLGCVLHRLADLEQ
          *  * ::  *****:*** *.:  **.*: :**  **::*  *.*
mOSM      KFLK----------TPAFPKLDSARHNILGIRNNVFCMARLLNHS
hOSM      RLPKAQDLERSGLNIEDLEKLQMARPNILGLRNNIYCMAQLLDNS
          :: *             : **: ** ****:***::***:**:.*
mOSM      LEIPEPTQTDSGASR---STTTPDVFNTKIGSCGFLWGYHRFMGS 
hOSM      D-TAEPTKAGRGASQPPTPTPASDAFQRKLEGCRFLHGYHRFMHS 
              ***::  ***:    * : *.*: *: .* ** ****** * 
mOSM      VGRVFREWDDGSTRSRR
hOSM      VGRVFSKWGESPNRSR-
          ***** :* :. .***           
          
B	
N-terminal D helix 











degradation	 (Fig.	 28B).	 A	 time-course	 experiment	monitoring	 recombinant	 protein	
expression	 in	 FreeStyle™	 293-F	 cells	 showed	 peak	 levels	 of	mOSM	production	 4-5	






blot	 of	 FreeStyle™	 293-F	 cell	medium	 3	 days	 after	 transfection	with	 the	 indicated	
vectors	containing	the	mature	mOSM	sequence,	using	penta-His	antibody	to	detect	
recombinant	protein	expression.	 (B)	Western	blot	of	FreeStyle™	293-F	cell	medium	
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cell	 stimulation	 assay	 (Fig.	 29A).	 In	 light	 of	 these	 results	 the	 different	 chimeric	
proteins,	along	with	the	WT	mOSM	version,	were	sequence-optimized	for	expression	
in	 mammalian	 cells	 and	 constructed	 from	 overlapping	 nucleotides	 designed	 with	
DNAWorks.	 (Hoover	 &	 Lubkowski	 2002)	 The	 different	 synthetic	 genes	 were	
assembled	through	PCR	and	cloned	into	the	pCAGGS	mammalian	expression	vector	
via	PacI	and	AscI	restriction	enzyme	sites	inserted	at	the	5'	and	3'	ends,	respectively.	
After	verification	of	 the	constructs	by	DNA	sequencing,	 they	were	 transfected	 into	
FreeStyle™	 293-F	 cells	 and	 His-tag	 purified,	 resulting	 in	 strong	 expression	 for	 the	





Figure	 29:	 Activity	 of	 recombinant	 mOSM	 and	 production	 of	 mOSM-based	
chimeras.	 (A)	 Western	 blot	 of	 NIH3T3	 cell	 samples	 subjected	 to	 a	 10-minute	









































Figure	 30:	 Short-term	 receptor	 activation	 ability	 of	 mOSM-based	 chimeric	
cytokines	 identifies	 the	 AB	 loop	 as	 a	 differential	 feature	 between	 human	 and	
murine	OSM.	 (A)	Western	blot	of	A375	cell	 samples	after	a	10-minute	stimulation	
with	25	ng/mL	of	WT	mOSM,	WT	hOSM,	WT	hLIF	and	the	four	mOSM-based	chimeric	
cytokines	 created.	 STAT3	 phosphorylation	 reflects	 hOSMR	 activation,	 while	 total	
STAT3	and	pan-Actin	serve	as	loading	controls.	(B)	Western	blot	of	JAR	cell	samples	
after	a	10-minute	stimulation	with	25	ng/mL	of	 the	detailed	cytokines.	 In	 this	case	
STAT3	 phosphorylation	 reflects	 hLIFR	 activation,	 while	 total	 STAT3	 and	 pan-Actin	
serve	 as	 loading	 controls.	 (C)	Quantitative	 analysis	 of	 hOSMR	and	hLIFR	 activation	
levels	after	a	10-minute	stimulation	treatment	with	the	indicated	cytokines,	relative	

























































































The	 same	 activation	 pattern	was	 observed	 after	 24-hour	 stimulation	 experiments.	
Expression	 levels	 of	 hOSMR	 and	 hLIFR	 target	 genes	 confirm	 the	 affinity	 of	 the	 AB	
loop	mOSM-based	 chimeras	 for	 both	 receptor	 complexes,	 as	 well	 as	 an	 apparent	
low-level	 binding	 of	 the	D	helix	 chimeras	 to	 the	 hLIFR	 complex	 (Fig.	 31A-C).	 Long-
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Quantitative	 analysis	 of	 hOSMR	 and	 hLIFR	 activation	 levels	 after	 a	 24-hour	
stimulation	treatment	with	the	detailed	chimeric	cytokines,	relative	to	the	observed	
activation	 for	 WT	 hOSM.	 Values	 were	 normalized	 against	 pan-Actin	 levels	 and	
presented	 as	 mean	 ±	 s.e.m.	 (n=5).	 (D)	 A375	 proliferation	 levels	 5	 days	 after	
stimulation	with	10	ng/mL	of	the	indicated	cytokines,	relative	to	the	proliferation	of	















which	 left	 seven	 candidate	 residues.	 Given	 that	 the	 alanine	 scanning	 experiment	
described	in	section	4.1.6	showed	no	effects	of	the	hOSM	mutants	E47A	and	H48A	
on	their	 receptor	activation	ability,	 the	analogous	A45	and	A46	residues	on	mOSM	
were	 judged	 unlikely	 to	 impact	 hOSMR	 activation	 and	 the	 five	 remaining	
substitutions	became	the	focus	of	this	study.	
	











Quadruple	 mutants	 were	 able	 to	 supplement	 additional	 information	 on	 the	
individual	impact	of	these	five	substitutions.	The	loss	of	activity	of	the	variant	lacking	









residues	 determining	 species	 specificity	 within	 the	 AB	 loop.	 (A)	Western	 blot	 of	
A375	 cell	 samples	after	 a	10-minute	 stimulation	with	25	ng/mL	of	WT	mOSM,	WT	
hOSM,	WT	 hLIF	 and	 the	 quadruple	 and	 quintuple	 mOSM	 point	 mutants	 detailed.	
STAT3	phosphorylation	 reflects	hOSMR	activation,	while	 total	STAT3	and	pan-Actin	
serve	 as	 loading	 controls.	 (B)	Western	 blot	 of	 JAR	 cell	 samples	 after	 a	 10-minute	
























































































































































































































































































































































































































































residues	 determining	 species	 specificity	 within	 the	 AB	 loop.	 (A)	Western	 blot	 of	
HepG2	 cell	 samples	 after	 a	 24-hour	 stimulation	with	 25	 ng/mL	 of	WT	mOSM,	WT	
hOSM,	WT	hLIF	and	the	quadruple	and	quintuple	mOSM	point	mutants.	TIMP1	levels	
reflect	 hOSMR	activation,	while	 total	 pan-Actin	 levels	 serve	 as	 loading	 control.	 (B)	
Western	 blot	 of	 JAR	 cell	 samples	 after	 a	 24-hour	 stimulation	 with	 the	 indicated	
cytokines.	 In	 this	case	STAT3	 levels	 reflect	hLIFR	activation,	while	pan-Actin	 level	 is	
used	as	a	 loading	control.	 (C)	Quantitative	analysis	of	hOSMR	and	hLIFR	activation	
levels	 after	 the	 24-hour	 stimulation	 treatment,	 relative	 to	 the	 observed	 activation	
for	WT	 hOSM.	 Values	 were	 normalized	 against	 pan-Actin	 levels	 and	 presented	 as	
















residues	 determining	 species	 specificity	 within	 the	 AB	 loop.	 (A)	Western	 blot	 of	
A375	 cell	 samples	after	 a	10-minute	 stimulation	with	25	ng/mL	of	WT	mOSM,	WT	






the	 indicated	 cytokines,	 relative	 to	 the	 observed	 activation	 for	WT	 hOSM.	 Values	
were	normalized	against	 total	 STAT3	 levels	 and	presented	as	mean	±	 s.e.m.	 (n=5).	
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pivotal	 role	 in	 permitting	 hOSMR	 activation.	 The	 24-hour	 and	 5-day	 stimulation	
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residues	 determining	 species	 specificity	 within	 the	 AB	 loop.	 (A)	Western	 blot	 of	








A375	 proliferation	 levels	 5	 days	 after	 stimulation	 with	 10	 ng/mL	 of	 the	 indicated	
cytokines,	relative	to	the	proliferation	of	the	control	group.	Values	are	given	as	mean	







After	examining	 the	ability	of	 the	 created	mutant	mOSM	cytokines	 to	activate	 the	
human	receptor,	 the	next	 logical	 step	was	 to	examine	whether	human	and	mouse	
OSMR	 are	 mutually	 exclusive	 by	 assessing	 the	 mOSMR	 activation	 ability	 of	 these	
variants.	 To	 this	 end,	 a	 suitable	 readout	 system	 had	 first	 to	 be	 developed	 to	
investigate	the	activation	of	the	different	murine	receptors.	
	
In	 contrast	 to	 the	 human	 situation,	 the	 available	 information	 regarding	 specific	
mLIFR-	 or	mOSMR-expressing	murine	 cell	 lines	 is	 very	 limited:	 the	NIH3T3	murine	
fibroblast	cell	line	had	been	reported	in	the	past	to	be	responsive	to	mOSM	but	not	




To	 ascertain	whether	NIH3T3	 cells	 could	be	used	 as	 a	 suitable	 readout	 system	 for	
mOSMR	 activation,	we	 first	 compared	 downstream	 STAT3	 phosphorylation	 after	 a	
10-minute	stimulation	with	both	mLIFR-	and	mOSMR-activating	cytokines	(Fig.	36A).	
The	presence	of	both	receptor	types	was	quite	apparent,	so	to	obtain	a	more	specific	
readout	 NIH3T3	 cells	 were	 stably	 transfected	 with	 an	 shRNA	 construct	 directed	
against	 mLIFR	 (Fig.	 36B).	 By	 comparing	 the	 phosphorylation	 pattern	 of	 these	






Figure	 36:	 STAT3	 phosphorylation	 after	 10	 minutes	 can	 be	 used	 to	 distinguish	
mOSMR	and	mLIFR	activation	 in	stably	transfected	NIH3T3	cells.	(A)	Western	blot	
of	STAT3	phosphorylation	 levels	 in	NIH3T3	cells	 stimulated	 for	10	minutes	with	25	
ng/mL	of	hLIF,	hOSM	and	mOSM.	Total	STAT3	and	pan-Actin	levels	serve	as	loading	
controls.	 (B)	Western	 blot	 showing	 STAT3	 phosphorylation	 levels	 in	 NIH3T3	 cells	
stably	transfected	with	shRNA	directed	against	mLIFR	after	a	10-minute	stimulation	




Efforts	 were	 also	 made	 to	 establish	 a	 second	 readout	 system	 to	 reliably	 confirm	
murine	 receptor	 activation.	 In	 the	 case	 of	 mOSMR,	 Richards	 and	 colleagues	 had	
reported	murine	TIMP1	(mTIMP1)	transcript	levels	to	be	upregulated	in	NIH3T3	cells	






























responsiveness	 to	mOSMR-	 and	mLIFR-activating	 cytokines,	 after	 10	minutes	 only	
those	 signaling	 through	 the	 mLIFR	 evidenced	 strong	 STAT3	 phosphorylation	 (Fig.	





cells,	 while	 STAT3	 phosphorylation	 reflects	 mLIFR	 activation	 in	 MH-S	 cells.	 (A)	
Western	 blot	 reflecting	 TIMP1	 expression	 levels	 in	 NIH3T3	 cells	 stimulated	 for	 24	
hours	with	25	ng/mL	of	hLIF,	hOSM	and	mOSM.	Pan-Actin	levels	serve	as	a	 loading	
control.	 (B)	Western	blot	showing	STAT3	phosphorylation	levels	in	MH-S	after	a	10-






terminal	 D-helix	 chimeras,	 could	 be	 assessed.	 In	 first	 place,	 the	 STAT3	
phosphorylation	 pattern	 in	 shRNA-mediated	 mLIFR	 knockdown	 (KD)	 NIH3T3	 cells	
was	unchanged	 in	 respect	 to	 the	control	 cell	 line,	 suggesting	 that	even	 the	mOSM	


















Figure	 38:	 Short-term	 stimulations	 with	 mOSM	 chimeras	 point	 at	 preserved	
mOSMR	 activation	 abilities.	 (A)	 Western	 blot	 of	 NIH3T3	 cell	 samples	 stably	
transfected	with	an	empty	vector	and	stimulated	 for	10	minutes	with	25	ng/mL	of	
the	 indicated	 cytokines.	 STAT3	 phosphorylation	 reflects	 mOSMR	 and/or	 mLIFR	











































































































































































































with	 25	 ng/mL	 of	 the	 indicated	 cytokines.	 mTIMP1	 expression	 reflects	 mOSMR	
activation,	with	pan-Actin	being	used	as	a	loading	control.	(B)	Western	blot	of	MH-S	
cell	samples	harvested	after	a	10-minute	stimulation	with	25	ng/mL	of	the	indicated	
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Figure	 40:	 Short-term	 stimulations	with	mOSM	 point	mutants	 hint	 at	 conserved	
mOSMR	 activation	 abilities.	 (A)	 Western	 blot	 of	 NIH3T3	 cell	 samples	 stably	
transfected	with	an	empty	vector	and	stimulated	 for	10	minutes	with	25	ng/mL	of	
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activation,	with	 total	STAT3	and	pan-Actin	serving	as	 loading	controls.	 (B)	Western	
blot	of	NIH3T3	cell	samples	stably	transfected	with	shRNA	against	mLIFR,	harvested	








Specific	 readouts	 confirmed	 that	 these	 variants	 show	 uneven	 mLIFR	 activation	
ability,	 closely	 reflecting	 their	 human	 receptor	 activation	 abilities,	 but	 all	 of	 them	
without	exception	were	still	capable	of	signaling	through	the	mOSMR	to	drive	TIMP1	
production	 in	 NIH3T3	 cells	 (Fig.	 41A-C).	 Taken	 together,	 these	 experiments	
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cytokines.	 In	 this	 case	 STAT3	 phosphorylation	 reflects	mLIFR	 activation,	 with	 total	






4.2.5.	 Substitutions	 in	 the	 residues	 involved	 in	 species	 specificity	 in	 human	
Oncostatin	M	enable	murine	OSMR	activation	
	
The	 lack	 of	 effect	 of	 any	 AB	 loop	 substitution	 in	 the	 activation	 of	 the	mOSMR	 by	
mOSM	greatly	contrasts	with	the	prior	observations	in	the	human	system,	and	might	
reflect	the	existence	of	a	different	binding	interface	not	involving	the	AB	loop	in	the	
mouse	 complex.	 To	 investigate	 this	 point	 in	 more	 detail,	 hOSM	 point	 mutants	
carrying	 the	 mouse	 residues	 in	 the	 pivotal	 positions	 identified	 for	 mOSM	 (G39N,	
V42T	and	K44D),	as	well	as	a	chimera	with	the	full	N-terminal	AB	loop	replaced	by	its	




proved	 critical	 for	 hOSMR	 activation	 in	 the	 alanine	 scanning	 experiment,	 every	










total	 STAT3	 and	 pan-Actin	 serve	 as	 loading	 controls.	 (B)	 Western	 blot	 of	 JAR	 cell	
samples	after	a	10-minute	stimulation	with	25	ng/mL	of	the	 indicated	cytokines.	 In	
this	case	STAT3	phosphorylation	reflects	hLIFR	activation,	while	total	STAT3	and	pan-
Actin	 serve	 as	 loading	 controls.	 (C)	 Quantitative	 analysis	 of	 hOSMR	 and	 hLIFR	
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This	 observation	 could	 be	 confirmed	 through	 the	 longer-term	 readout	 systems:	
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A	 hOSM point mutants 
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of	 hOSMR	 and	 hLIFR	 activation	 levels	 after	 the	 24-hour	 stimulation	 experiments,	
relative	 to	 the	 observed	 activation	 for	WT	 hOSM.	Values	were	 normalized	 against	
pan-Actin	levels	and	presented	as	mean	±	s.e.m.	(n=5).	(D)	A375	proliferation	levels	
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Figure	 44:	 Short-term	 stimulations	 with	 hOSM-based	mutants	 indicate	 apparent	
mOSMR	 activation	 abilities.	 (A)	 Western	 blot	 of	 NIH3T3	 cell	 samples	 stably	
transfected	with	an	empty	vector	and	stimulated	 for	10	minutes	with	25	ng/mL	of	
the	 indicated	 cytokines.	 STAT3	 phosphorylation	 reflects	 mOSMR	 and/or	 mLIFR	










Confirmatory	 experiments	 employing	 specific	 readouts	 left	 no	 doubt	 that	 K44	 is	
responsible	 for	 the	 lack	of	 cross-species	 reactivity	 of	 hOSM	with	 the	mOSMR,	 and	
that	its	substitution	by	aspartic	acid	is	sufficient	for	the	mutant	cytokine	to	display	a	
signaling	 ability	 in	 murine	 cells	 that	 mirrors	 the	 human	 situation	 (Fig.	 45A-C).	
Furthermore,	these	mutants	 indicate	that	the	AB	loop	of	the	cytokine	does	play	an	







Figure	 45:	 Specific	 readout	 system	 confirms	 acquisition	 of	mOSMR	 activation	 by	
hOSM	 variants.	 (A)	Western	 blot	 of	 NIH3T3	 cell	 samples	 stimulated	 for	 24	 hours	
with	 25	 ng/mL	 of	 the	 indicated	 cytokines.	 mTIMP1	 expression	 reflects	 mOSMR	
activation,	with	pan-Actin	being	used	as	a	loading	control.	(B)	Western	blot	of	MH-S	
cell	samples	harvested	after	a	10-minute	stimulation	with	25	ng/mL	of	the	indicated	
cytokines.	 In	 this	 case	 STAT3	 phosphorylation	 reflects	mLIFR	 activation,	 with	 total	














































hOSM point mutants 























hOSM point mutants 























B	 hOSM point mutants 































N-terminal	 helix	 D	 sequences	 in	 hLIF	 by	 their	 corresponding	 hOSM	 sequence	was	
required	 for	 the	 chimeric	 cytokine	 to	 signal	 through	 the	 hOSMR	 complex.	 (B)	
Replacement	of	 the	AB	 loop	of	mOSM	by	the	human	 loop	enabled	the	cytokine	to	
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The	 availability	 of	 detailed	 data	 on	 cytokine-receptor	 interactions	 for	 potential	
immunotherapeutic	cytokines	is	critical,	as	it	has	led	to	the	development	of	a	whole	
new	approach	 to	 protein	 engineering:	 by	 employing	 this	 information	 as	 a	 basis	 to	




the	 crystal	 structure	 of	 the	 complex	 between	 IL-6,	 the	 IL6R	 and	 the	 extracellular	
region	of	gp130	provided	detailed	information	on	the	interacting	residues	between	
these	molecules.	(Boulanger,	Chow,	et	al.	2003)	The	same	holds	true	for	many	of	the	
other	 IL-6	 family	 members:	 crystallization	 experiments	 have	 provided	 valuable	




In	 contrast,	 despite	 the	 fact	 that	 OSM	 possesses	 the	 broadest	 signaling	 abilities	
within	 the	 IL-6	 class	 and	 thus	 the	 widest	 range	 of	 possible	 applications,	 little	
evidence	 regarding	 the	 interaction	 between	 OSM	 and	 its	 receptor	 complexes	 is	
available	to	date.	(Hermanns	2015)	 In	order	to	address	this	 lack	of	 information	the	
present	 work	 employs	 molecular	 biology	 tools	 such	 as	 the	 creation	 of	 chimeric	
proteins,	 successfully	 used	 in	 the	 past	 to	 examine	 differences	 in	 binding	 and	
downstream	 signaling	 in	 a	 variety	 of	 receptor	 systems	 including	 OSMR,	 LIFR	 and	
gp130.	(Kallen	et	al.	1999)	(Hermanns	et	al.	1999)	
	
By	these	means	the	particular	 features	of	hOSM	that	enable	 it	 to	activate	multiple	
receptors	 could	 be	 identified,	 and	 variants	 with	 a	 modified	 receptor	 activation	
profile	 in	respect	 to	the	native	human	cytokine	could	be	obtained.	 In	addition,	 the	
same	 techniques	 were	 applied	 to	 locate	 the	 molecular	 determinants	 causing	 the	
well-described	difference	 in	 receptor	 specificity	between	hOSM	and	mOSM,	which	
hinders	the	translation	of	results	obtained	in	murine	models	to	the	human	situation.	




Finally,	 the	data	collected	 in	 this	work	supports	 the	possibility	 that	OSM	may	have	
adopted	an	evolutionary	path	so	far	unreported	for	other	cytokines,	attaining	a	new	
function	 through	 the	evolution	of	 a	 promiscuous	 intermediate	which	would	 finally	






The	 experiments	 comprising	 this	 work	 relied	 on	 the	 ability	 to	 express	 and	 purify	
several	 wild-type	 cytokines	 (hOSM,	 hLIF	 and	 mOSM),	 as	 well	 as	 different	 point	
mutants	 and	 chimeric	 proteins.	 This	 is	 generally	 a	 laborious	 and	 time-consuming	
process:	 these	 particular	 proteins	 tend	 to	 aggregate	 and	 form	 insoluble	 inclusion	






To	 improve	 on	 the	 reported	methods,	 two	 different	 solutions	were	 developed:	 at	
first,	 soluble	 prokaryotic	 expression	was	 achieved	 by	 employing	 a	modified	E.	 coli	
strain	 expressing	 a	 chaperone/disulfide	 bond	 isomerase.	 This	 method	 led	 to	 the	






perhaps	 due	 to	 the	 substantial	modifications	 in	 their	 native	 amino	 acid	 sequence.	
This	 led	 to	 a	mammalian	 expression	 system	 being	 established:	 human	 FreeStyle™	
293-F	 cells	 proved	 able	 to	 produce	 recombinant	 proteins,	 including	 the	 chimeric	
variants,	in	sufficient	amounts	for	later	use	in	stimulation	experiments.	The	fact	that	
these	cells	are	adapted	to	serum-free	medium	facilitated	downstream	recovery	and	
purification	 of	 the	 recombinant	 proteins.	 In	 both	 prokaryotic	 and	 mammalian	
expression	 systems	 the	 presence	 of	 a	 C-terminal	His-tag	 enabled	 the	 recombinant	
proteins	to	be	purified	using	Ni-NTA	affinity	resins.	(Schmitt	et	al.	1993)	
	
In	 respect	 to	monitoring	 receptor	 activation	 in	 response	 to	 the	 array	 of	 cytokines	
created,	 the	 short-term	 indicator	 selected	 was	 downstream	 phosphorylation	 of	
STAT3.	As	discussed	in	section	1.3,	this	signaling	component	is	shared	by	all	the	IL-6	
family	receptors	and	plays	a	crucial	role	after	their	activation:	OSM	is	no	exception,	
as	 STAT3	 mediates	 most	 of	 its	 biological	 effects	 including	 hematopoiesis,	
cardioprotection	and	liver	regeneration.	(Takizawa	et	al.	2003)	(Hilfiker-Kleiner	et	al.	
2004)	 (Lörchner	 et	 al.	 2015)	 (Li	 et	 al.	 2002)	 (Nakamura	 et	 al.	 2004)	 By	 taking	
advantage	of	well-characterized	cell	lines	exclusively	expressing	hOSMR	or	hLIFR,	as	
well	 as	 novel	 mOSMR	 or	 mLIFR-specific	 cell	 types	 in	 the	 murine	 situation,	 STAT3	
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the	 initial	 observations	 derived	 from	 the	 measurement	 of	 STAT3	 phosphorylation	
levels	 after	 a	 10-minute	 stimulation.	 In	 the	 case	 of	 OSMR	 activation,	 TIMP1	 was	
selected	as	a	known	specific	target	of	this	receptor	in	contrast	to	the	LIFR:	24	hours	
of	stimulation	are	sufficient	 for	TIMP1	expression	 levels	 to	 increase	dramatically	 in	
both	 human	 and	 murine	 systems.	 (Richards	 et	 al.	 1993)	 (Bugno	 et	 al.	 1995)	 In	
addition,	 given	 that	 hOSM	 was	 first	 identified	 as	 a	 proliferation	 inhibitor	 in	 a	





line	and	monitor	 total	 STAT3	 levels	after	24	hours	as	a	 reflection	of	hLIFR	activity.	






in	 the	past	 that	 the	hOSM	residues	F160	and	K163	are	critical	 for	hOSMR	binding.	
(Deller	 et	 al.	 2000)	As	 a	 consequence,	when	 the	phenylalanine	and/or	 lysine	were	












the	 only	 structural	 feature	 involved	 in	 hOSMR	 recognition.	 Structural	 comparisons	
















replacements	 of	 as	 little	 as	 10	 amino	 acids	 by	 their	 corresponding	 hLIF	 residues	
resulted	 in	 chimeric	 cytokines	 that	were	unable	 to	 initiate	hOSMR	 signaling,	while	
still	 displaying	normal	 function	 through	 the	hLIFR.	After	 this	 initial	 finding,	 alanine	
mutants	of	all	 individual	positions	within	the	AB	loop	of	human	OSM	led	to	a	more	





receptors	 or	 an	 improper	 structural	 organization	 of	 the	 L40A	mutant.	 This	 second	
supposition	appears	more	likely,	since	amino	acids	with	aliphatic	side	chains	such	as	
leucine	 are	 very	 non-reactive:	 they	 tend	 to	 be	 buried	 in	 the	 protein	 interior,	
particularly	 in	 alpha	 helices,	 seldom	 being	 directly	 involved	 in	 protein	 function.	
(Betts	&	Russell	2003)	Disruption	of	the	secondary	structure	of	hOSM	also	explains	
the	 lack	 of	 signaling	 by	 the	 C49	 mutant,	 as	 this	 residue	 is	 part	 of	 an	 essential	
disulfide	bond	between	C49	and	C167.	 (Kallestad	et	 al.	 1991)	 The	presence	of	 the	
disulfide	 bond	 likely	 ensures	 that	 all	 regions	 of	 binding	 site	 III	 are	 in	 the	 correct	
orientation	and	distance	to	interact	with	the	receptor.	
	
Additionally,	 the	 alanine	 scanning	 analysis	 performed	 uncovered	 four	 different	
residues	 in	the	AB	loop	that	seem	to	be	exclusively	required	for	hOSMR	activation.	
Stimulation	 with	 Q38,	 G39	 and	 L45	 mutants	 led	 to	 normal	 hLIFR	 activation	 but	
complete	 absence	 of	 hOSMR-dependent	 signaling,	 while	 Y34	 resulted	 in	 partial	
impairment	of	hOSMR	activation.	
	






side	 chains	 or	 charged	 atoms.	 (Betts	 &	 Russell	 2003)	 An	 example	 of	 one	 such	
interaction	 is	 the	 bovine	 papillomavirus	 type	 1	 E5	 oncoprotein,	 in	 which	 a	 single	





The	 glycine	 in	 position	 39	 is	 perhaps	 the	 most	 intriguing	 of	 the	 four	 identified	
residues,	given	the	influence	it	also	has	in	species-specific	OSMR	activation.	Glycine	
is	 the	 amino	 acid	 with	 the	 smallest	 side	 chain,	 containing	 only	 a	 hydrogen	 atom	
without	any	carbons:	this	 leads	to	a	much	higher	conformational	 flexibility,	so	that	
glycine	can	be	found	in	structures,	such	as	tight	turns,	in	which	no	other	amino	acid	
can	 reside.	 (Betts	&	 Russell	 2003)	 This	 particularity	 also	 allows	 glycine	 to	 perform	
unique	 functional	 roles,	 such	 as	 binding	phosphates	 through	 its	 backbone	without	










or	 L45,	 is	 the	 tyrosine	 in	 position	 34.	 This	 partially	 hydrophobic	 amino	 acid	 is	
regularly	found	buried	in	protein	cores,	but	unlike	leucine	the	side	chain	of	tyrosine	
contains	an	aromatic	ring	with	a	reactive	hydroxyl	group,	which	makes	it	more	likely	
to	 interact	 with	 atoms	 other	 than	 carbon.	 (Betts	 &	 Russell	 2003)	 In	 particular,	
aromatic	amino	acids	have	been	proposed	to	be	able	to	stack	on	top	of	each	other,	
with	 their	 aligned	 aromatic	 rings	 creating	 an	 electrostatic	 interaction	 between	
proteins.	(Hunter	et	al.	1991)	
	
If	 this	 were	 the	 case,	 Y34	 of	 hOSM	 would	 be	 interacting	 with	 a	 phenylalanine,	
tryptophan,	 histidine	 or	 another	 tyrosine	 in	 the	 binding	 interface	 of	 the	 hOSMR.	
However,	this	possible	interaction	would	not	be	essential	for	hOSMR	binding	and/or	
activation,	 since	 alanine	 replacement	 of	 Y34	 only	 causes	 a	 partial	 impairment	 of	
signaling.	
	
While	 the	 importance	 of	 the	 AB	 loop	 in	 terms	 of	 hOSMR	 activation	 appears	 clear	
based	 on	 the	 data	 presented,	 the	 exact	 mechanism	 behind	 the	 observed	 loss	 of	
signaling	has	yet	to	be	determined.	Taking	 into	account	the	nature	of	the	common	
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activation	 mechanism	 for	 type	 I	 cytokine	 receptor	 complexes,	 which	 undergo	
conformational	 changes	 that	 lead	 to	 transphosphorylation	 in	 their	 cytoplasmatic	
regions,	there	seem	to	be	two	main	possibilities	to	explain	this	lack	of	activation.	
	
Perhaps	the	most	 intuitive	hypothesis	 is	that	the	mutant	cytokine	completely	 loses	
its	ability	 to	bind	the	hOSMR	due	to	changes	 in	 its	AB	 loop.	However,	 it	cannot	be	
ruled	 out	 that	 this	 AB	 loop	 modification	 would	 result	 in	 a	 molecule	 that	 still	
maintains	 affinity	 for	 the	 hOSMR,	 but	 is	 no	 longer	 able	 to	 induce	 the	 required	
conformational	changes	to	initiate	intracellular	signaling	after	ligand	binding.	
	




sample	 required	and	 the	 speed	and	 reliability	of	 its	 results.	 (Besenicar	et	al.	2006)	
(Pierce	 et	 al.	 1999)	 However,	 applying	 these	 techniques	 to	 study	 the	 binding	 of	
hOSM	to	the	hOSMR/gp130	complex	has	proved	challenging:	both	ITC	and	SPR	rely	
on	 reconstituting	 the	 ligand-receptor	 system	 outside	 the	 cellular	 environment,	 in	
solution	for	ITC	and	in	a	sensor	chip	for	SPR.	Unfortunately,	the	lack	of	direct	OSM	-	







cytokines	 with	 iodine	 125	 and	 measuring	 binding	 of	 increasing	 amounts	 of	 the	
cytokine	 to	a	monolayer	of	A375	cells,	a	Scatchard	analysis	could	be	performed	to	
determine	its	affinity	constants.	(Linsley	et	al.	1989)	In	this	manner,	WT	hOSM	could	
be	compared	to	 the	mutants	of	 interest	 to	determine	whether	 replacement	of	 the	
AB	 loop	 has	 a	 direct	 effect	 on	 receptor	 binding	 ability,	 or	 only	 affects	 the	
conformational	changes	required	for	signaling	initiation	after	binding.	
	




would	 suggest	 the	 existence	 of	major	 differences	 in	 this	 region	 between	 hLIF	 and	
hOSM.	However,	a	close	examination	of	the	aligned	loop	regions	reveals	this	not	to	
be	 the	 case:	 in	 fact,	 the	 four	 key	 hOSM	 amino	 acids	 (Y34,	 Q38,	 G39	 and	 L45)	










to	 be	 exposed	 in	 the	 protein	 surface,	 and	 can	 form	 salt	 bridges	 with	 positively	
charged	 residues	 to	 contribute	 to	 protein	 stability	 or	 protein-protein	 interactions.	






However,	 the	 main	 differential	 feature	 between	 the	 AB	 loops	 of	 hOSM	 and	 hLIF	
seems	to	be	the	presence	of	an	additional	amino	acid	in	the	hLIF	sequence	(Fig.	15A).	
Taking	into	account	that	the	nearby	cysteine	has	a	fixed	spatial	position	due	to	the	
disulfide	 bond	 it	 forms	 with	 helix	 D	 in	 both	 cytokines,	 the	 presence	 of	 an	 extra	
residue	 in	 the	 hLIF	 AB	 loop	 results	 in	 the	 spatial	 rearrangement	 of	 most	 of	 the	
residues	forming	this	region.	In	this	way,	even	if	nearly	all	the	amino	acids	necessary	



























Many	more	differences	between	these	two	proteins	can	be	 found	 in	other	 regions	
outside	 the	 AB	 loop,	 but	 previous	 reports	 indicated	 that	 in	 the	 case	 of	 hLIFR	
interaction	the	regions	outside	binding	site	 III	 (N-terminal	AB	 loop,	BC	 loop	and	N-
terminal	helix	D)	do	not	appear	to	play	a	major	role.	(Kallen	et	al.	1999)	Thus	when	
the	binding	site	III	regions	of	CNTF	were	transferred	to	another	IL-6	family	member,	
such	 as	 IL-6,	 the	 chimeric	 protein	 acquired	 the	 ability	 to	 initiate	 hLIFR	 signaling	
without	additional	modifications.	(Kallen	et	al.	1999)	
	
To	determine	whether	 this	was	also	 the	 case	 for	 the	hOSMR,	hLIF-based	chimeras	
incorporating	 hOSM	 site	 III	 regions	were	 employed.	 These	 experiments	 evidenced	
that	 a	 combined	 replacement	 of	 the	N-terminal	AB	 loop	 and	N-terminal	D	 helix	 is	
sufficient	 to	enable	hOSMR	signaling	by	hLIF,	 confirming	binding	 site	 III	 as	 the	key	
region	modulating	 recognition	 of	 the	 different	 gp130	 co-receptors	 within	 the	 IL-6	
family.	 It	should	be	stressed,	however,	 that	other	regions	 in	hOSM	outside	binding	
site	III	also	impact	hOSMR	interaction,	as	the	AB	loop	and	D-helix	regions	only	confer	








the	 human	 and	 murine	 OSM	 orthologs	 was	 originally	 described	 20	 years	 ago.	






Despite	 this	 being	 a	well-known	phenomenon,	 the	 underlying	mechanisms	 behind	
these	 species-dependent	 modes	 of	 action	 had	 never	 been	 addressed	 until	 now.	
Through	the	generation	of	human/mouse	OSM	chimeric	cytokines,	this	work	proves	






Following	up	on	 this	 initial	 result,	 the	creation	of	different	combinations	of	mOSM	
point	mutants	within	the	identified	region	resulted	in	a	more	accurate	identification	








helix	 D	 regions	 of	 hOSM	 (left)	 and	mOSM	 (middle)	 are	 depicted,	 with	 the	 critical	
residues	differentiating	both	cytokines	highlighted	in	red.	A	mOSM	variant	with	the	







come	 as	 no	 surprise	 that	 only	 mOSM	 mutant	 proteins	 incorporating	 the	 N37G	
replacement	became	capable	of	activating	the	hOSMR.	However,	while	the	presence	

















the	 substituting	 residue,	 and	 not	 of	 the	 lysine	 itself:	 while	 both	 are	 polar	 amino	




AB	 loop	 may	 not	 be	 a	 strict	 requirement	 for	 hOSMR	 binding,	 it	 appears	 that	 a	
negatively	 charged	 amino	 acid	 in	 the	 same	 position	 can	 hinder	 human	 receptor	
activation.	The	opposite	applies	 for	the	mouse	receptor,	since	the	presence	of	K44	
appears	to	be	the	main	factor	impeding	mOSMR	activation	by	the	human	cytokine:	




In	 addition	 to	 N37G	 and	 D42K,	 the	 replacement	 of	 threonine	 40	 by	 the	







activate	 the	 mOSMR:	 this	 could	 be	 explained	 by	 the	 influence	 of	 other	 regions	
outside	binding	site	III	in	OSMR	interaction,	as	first	discussed	in	section	5.1.	Although	
the	AB	 loop	clearly	plays	an	 important	 role	 in	mOSMR	activation,	mOSM	has	 likely	
incorporated	 additional	 modifications	 in	 other	 regions	 of	 the	 protein	 favoring	
receptor	 interaction,	 which	 would	 allow	 for	 a	 certain	 degree	 of	 flexibility	 in	 the	







directional	 selection,	 defined	 as	 a	 selection	 process	 favoring	 change:	 as	 a	 result	
these	 genes	 evolve	 rapidly,	 most	 likely	 in	 order	 to	 enhance	 the	 ability	 of	 the	
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organism	 to	 respond	 against	 new	pathogens.	 (Hurst	&	 Smith	 1999)	 In	 light	 of	 this	
fact,	 it	 should	 come	 as	 no	 surprise	 that	 cytokines	 are	 among	 the	 most	 rapidly	
evolving	genes	in	vertebrates.	(Scapigliati	et	al.	2006)	
	
Additionally,	 it	 is	clear	 that	gene	duplication	processes	have	played	a	major	role	 in	
the	 diversification	 of	 both	 cytokines	 and	 its	 receptors:	 only	 two	 type	 I	 cytokine	
receptors,	one	of	which	is	homologous	to	gp130,	were	identified	in	an	urochordate	
(sea	 squid,	Ciona	 intestinalis),	which	diverged	 from	vertebrates	 approximately	 794	
million	 years	 ago.	 (Liongue	&	Ward	 2007)	 In	 contrast	 27	 core	 receptors,	 including	
members	of	all	5	structural	groups	present	in	mammals,	could	be	traced	to	the	last	
common	 ancestor	 between	 teleosts	 and	 mammals,	 which	 separated	 around	 476	
million	years	ago.	(Liongue	&	Ward	2007)	
	
IL-6	 family	 cytokines	 and	 its	 receptors	 are	 no	 exception,	 showing	 clear	 signs	 of	 a	
common	 origin	 through	 gene	 duplication:	 this	 is	 most	 evident	 for	 LIF	 and	 OSM,	
which	are	linked	in	tandem	in	human	chromosome	22q12.	(Rose	et	al.	1993)	(Jeffery	
et	 al.	 1993)	 (Giovannini	 et	 al.	 1993)	 LIFR	 and	 OSMR	 are	 also	 thought	 to	 have	
originated	 after	 duplication	 of	 a	 common	 ancestral	 receptor,	 as	 they	 are	 found	
within	a	cluster	of	cytokine	 receptor	 loci	 in	 the	chromosome	5p12-p13	 in	humans.	





This	 work	 offers	 detailed	 molecular	 insight	 on	 a	 possible	 mechanism	 for	 the	
evolution	 of	 new	 cytokines.	 Human	 and	murine	 LIF	 sport	 around	 80%	 amino	 acid	
identity,	 compared	 to	 the	approximately	50%	observed	 for	OSM,	 implying	 that	 LIF	










this	 theory,	 the	 most	 evolutionarily	 favorable	 path	 for	 the	 evolution	 of	 a	 new	





In	 this	 way	 protein	 evolution	 would	 take	 place	 gradually,	 with	 very	 unspecific	
primitive	 enzymes	 steadily	 giving	way	 to	more	 specialized	 ones	 by	means	 of	 gene	
duplication	 and	 divergence	 processes,	 resulting	 in	 increased	 metabolic	 efficiency.	
(Khersonsky	et	al.	2006)	It	has	also	been	shown	that	a	small	number	of	modifications	
in	 the	 amino	 acid	 sequence	 of	 an	 enzyme	 can	 lead	 to	 drastic	 changes	 in	 their	
substrate	affinity:	as	an	example,	the	replacement	of	a	single	residue	in	a	bacterial	
endopeptidase	 was	 sufficient	 for	 it	 to	 specifically	 cleave	 alanine-arginine	 bonds	












The	 acquisition	 of	 specificity	 can	 be	 attributed	 to	 the	 well-described	 evolutionary	
pressures	favoring	specificity	 in	complex	biological	 interaction	networks	 in	order	to	
minimize	 crosstalk.	 (Capra	 et	 al.	 2012)	 Thus,	 proteins	 participating	 in	 signaling	
pathways	that	are	derived	from	a	common	origin	have	often	incorporated	mutations	






work	 indicates	 that	 this	 step	 would	 have	 involved	 the	 development	 of	 additional	
interactions	between	mOSM	and	the	mOSMR,	enabling	the	cytokine	to	modify	its	N-
terminal	 AB	 loop	 in	 such	 a	 way	 as	 to	 inhibit	 mLIFR	 activation	 while	 maintaining	
mOSMR	activity.	Phylogenetic	analyses	 for	OSM	and	the	OSMR	are	consistent	with	











Despite	 the	 amount	 of	 circumstantial	 evidence	 available,	 conclusive	 proof	 of	 this	
hypothesis	would	most	likely	require	the	identification	of	the	ligand-receptor	binding	
interfaces	 in	both	human	and	mouse	 systems,	which	 remain	unknown	 so	 far.	 This	
could	 be	 achieved	 by	 cross-linking	 techniques	 coupled	 with	 mass	 spectrometry,	






Protein-based	 therapies	 constitute	 a	 particularly	 promising	 approach	 in	 the	 search	
for	 new	 medical	 treatments,	 since	 they	 are	 generally	 more	 specific	 and	 better	




Within	 this	 frame,	 interest	 in	 the	 therapeutic	 applications	 of	 external	 OSM	
administration	 has	 steadily	 increased	 since	 the	 initial	 description	 of	 its	 beneficial	
effects	 in	 a	 murine	model	 of	 myocardial	 infarction	 (MI).	 (Kubin	 et	 al.	 2011)	 OSM	
cardioprotection	 is	mediated	by	different	mechanisms:	 the	 first	of	 these	 is	a	direct	
effect	 on	 cardiomyocytes,	 promoting	 their	 dedifferentiation	 and	 enabling	 them	 to	
better	survive	the	hypoxic	conditions	characteristic	of	a	MI	injury.	(Pöling	et	al.	2012)	
Additionally,	OSM	is	able	to	modulate	the	response	of	the	immune	system	after	MI,	





autophagy	 in	order	 to	 limit	cardiac	 remodeling	after	 infarction.	 (Zhang	et	al.	2015)	
(Hu	 et	 al.	 2017)	 OSM	 also	 proved	 able	 to	 alleviate	 cardiac	 injury	 in	 diabetic	mice	
through	the	inhibition	of	apoptotic	processes.	(Sun	et	al.	2015)	In	addition	to	acute	
heart	 disease,	 potential	 therapeutic	 usage	 of	 OSM	 has	 also	 been	 extended	 to	
cerebral	 ischemic	 stroke	 and	 spinal	 cord	 injury	 in	 other	 works.	 (Guo	 et	 al.	 2015)	
(Slaets	et	al.	2014)	
	





promote	 cardiomyocyte	 survival	 and	 stimulate	 regeneration	 after	 MI.	 (Zou	 et	 al.	
2003)	 (Kanda	et	al.	2016)	 In	addition,	 LIF	administration	outside	 the	context	of	MI	






reported	 increase	 in	 platelet	 numbers,	 which	 was	 significantly	 higher	 for	 LIFR-
activating	cytokines	in	a	comparative	study.	(Juan	et	al.	2009)	This	is	due	to	the	link	











Along	 this	 line,	 future	 research	 plans	 are	 focused	 on	 assessing	 the	 impact	 of	 this	
human-like	mouse	OSM	 in	 vivo	 in	 terms	of	 survival	 and	 functional	 recovery	of	 the	
heart	 after	 MI,	 and	 comparing	 its	 beneficial	 effects	 to	 those	 evidenced	 by	 the	










Finally,	 the	 generation	 of	 a	 transgenic	 mouse	 strain	 incorporating	 the	 described	
promiscuity-inducing	 substitutions	 into	 the	 endogenous	 mOSM	 sequence	 would	
result	 in	a	humanized	mouse	model	of	OSM	action.	Humanized	models	have	been	
extensively	 used	 in	 the	 field	 of	 human	 hematopoiesis	 and	 immune	 function	 to	
minimize	 the	 significant	 differences	 developed	 between	 the	 murine	 and	 human	
immune	 systems	 after	 65-75	 million	 years	 of	 evolution,	 ranging	 from	 a	 different	
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lymphocyte/neutrophil	 balance	 to	 variations	 in	 cytokines/chemokines	 and	 its	
corresponding	receptors.	(Mestas	&	Hughes	2004)	
	
Thus,	 in	 order	 to	 minimize	 the	 discrepancy	 between	murine	 and	 human	 immune	
system	 biology,	 increasingly	 sophisticated	 humanized	 mouse	 models	 have	 been	
developed	 since	 the	 human	 growth	 hormone	 gene	was	 first	 introduced	 into	mice	
more	than	30	years	ago.	(Brinster	&	Palmiter	1984)	Nowadays	such	models	employ	
genetically	modified	mice	 strains	 carrying	mutations	 leading	 to	 immunodeficiency,	





Complemented	 with	 the	 substitution	 of	 several	 murine	 immunomodulatory	
cytokines	 by	 their	 human	 orthologs,	 the	 degree	 of	 complexity	 achieved	 by	 such	 a	
humanized	mouse	immune	system	can	approach	that	of	the	native	human	system	in	
terms	 of	 subset	 diversity	 and	 numbers.	 (Rongvaux	 et	 al.	 2014)	 The	 use	 of	 these	
humanized	murine	models	has	been	instrumental	in	the	study	of	processes	such	as	
early	human	hematopoietic	development,	the	 initiation	of	acute	myeloid	 leukemia,	
infectious	 diseases	 that	 exclusively	 target	 human	 cells	 such	 as	 the	 human	
immunodeficiency	 virus	 (HIV)	 or	 autoimmune	 diseases,	 among	 many	 others.	
(Doulatov	 et	 al.	 2010)	 	 (Lapidot	 et	 al.	 1994)	 (Rämer	 et	 al.	 2011)	 (Namikawa	 et	 al.	
1988)	(Brehm	et	al.	2010)	
	
In	 case	of	OSM,	 the	 generation	of	 a	 humanized	 animal	model	would	 facilitate	 the	
study	of	its	physiological	actions	in	vivo	in	a	manner	more	easily	translatable	to	the	
human	situation,	while	at	the	same	time	avoiding	the	difficulties	presented	by	other	




In	 conclusion,	 the	 work	 presented	 offers	 substantial	 insight	 into	 the	 structural	
features	 determining	 OSM	 interaction	 with	 its	 receptors	 in	 both	 the	 human	 and	
murine	 systems.	 This	 knowledge	 has	 important	 evolutionary	 implications	 for	 OSM	
and	cytokines	as	a	whole,	suggesting	a	 likely	evolutionary	path	after	duplication	of	
the	ancestral	protein	 through	promiscuous	 intermediates.	 In	addition,	 some	of	 the	
OSM	 variants	 created	 are	 expected	 to	 have	 promising	 applications	 in	 the	 field,	






Oncostatin	M	 (OSM)	 is	 a	 prominent	member	 of	 the	 IL-6	 cytokine	 family.	 It	 signals	
through	 a	 heterodimeric	 OSM	 receptor/gp130	 (OSMR)	 complex,	 specific	 for	 this	
cytokine	 and	 driving	 its	 many	 biological	 effects.	 Especially	 interesting	 are	 its	
potential	 therapeutic	 applications,	 as	 OSM	 has	 been	 beneficial	 in	 several	 murine	
cardiovascular	disease	models.	Unfortunately,	 the	translatability	of	 these	results	 to	
the	human	situation	is	not	assured	due	to	the	different	receptor	activation	abilities	
of	human	and	mouse	OSM	(hOSM/mOSM).	While	mOSM	 is	 specific	 for	 the	OSMR,	
hOSM	 signals	 through	 the	 leukemia	 inhibitory	 factor	 receptor/gp130	 (LIFR)	 in	
addition	 to	 the	 OSMR,	 which	 could	 result	 in	 additional	 effects	 besides	 those	
reflected	in	preclinical	mouse	models.	Taken	together,	there	is	a	clear	need	for	more	















create	 hOSM/hLIF	 chimeras.	 Cell-stimulation	 experiments	 using	 these	 chimeric	
variants	pointed	to	the	N-terminal	AB	loop	and	N-terminal	helix	D	regions	of	hOSM	
as	 responsible	 for	 hOSMR	 signaling,	 enabling	 hOSMR	 activation	 by	 a	 hLIF-based	
chimera	 with	 these	 two	 hOSM	 regions.	 Subsequently,	 site-directed	 mutagenesis	




mapped	 to	 its	 N-terminal	 AB	 loop	 by	 means	 of	 chimeric	 mouse/human	 OSM	
cytokines.	 In	 this	 case,	 point	mutagenesis	 experiments	 revealed	 residues	N37,	 T40	
and	 D42	 of	 the	 murine	 cytokine	 to	 be	 responsible	 for	 mOSMR	 specificity.	 This	
specificity	was	 lost	 upon	 replacing	 these	 amino	acids	by	 their	 hOSM	counterparts,	
resulting	 in	 a	 mOSM	 variant	 able	 to	 activate	 mLIFR	 as	 well	 as	 mOSMR.	 Finally,	
phylogenetic	 analyses	 indicated	 that	 the	 acquisition	of	 specificity	 likely	 constitutes	
	 119	








the	 loss	of	 the	ancestral	 function	 (LIFR	activation)	 to	attain	 specificity.	 In	 addition,	
some	of	the	mOSM	mutants	generated	are	expected	to	improve	the	translatability	of	
future	 research	 on	 the	 therapeutic	 applications	 of	 OSM.	 Given	 that	 these	mutant	
variants	 possess	 a	 human-like	 receptor	 signaling	 profile,	 their	 use	 in	 murine	







Oncostatin	 M	 (OSM)	 ist	 ein	 Zytokin	 der	 Interleukin-6	 Familie.	 Die	 vielfältigen	
biologischen	 Funktionen	 von	 OSM	 werden	 auf	 molekularer	 Ebene	 durch	 die	
Aktivierung	 eines	 spezifischen	 heterodimeren	 Rezeptorkomplexes,	 bestehend	 aus	
OSM	 Rezeptor	 (OSMR)	 und	 gp130,	 vermittelt.	 Dabei	 implizieren	 insbesondere	 die	
aus	murinen	 Tiermodellen	 gewonnenen	 Erkenntnisse	 eine	 protektive	Wirkung	 von	
OSM	 in	 der	 Progression	 diverser	 kardiovaskulärer	 Erkrankungen.	 Eine	 direkte	
Ableitung	 für	 den	Mensch	 und	 Fortführung	 translationaler	 Studien	wird	 allerdings	
durch	 speziesspezifische	 Unterschiede	 in	 der	 Aktivierung	 unterschiedlicher	
Rezeptordimere	 erschwert.	 So	 vermittelt	 murines	 OSM	 (mOSM)	 seine	 Effekte	
exklusiv	 durch	 den	 OSMR/gp130	 Komplex,	 wohingegen	 humanes	 OSM	 (hOSM)	
zusätzlich	den	 leukemia	 inhibitory	 factor	 receptor	 (LIFR)/gp130	Komplex	aktivieren	
kann.	 Insbesondere	 vor	 dem	 Hintergrund	 einer	 potentiell	 therapeutischen	
Bedeutung	 bedarf	 es	 weiterführende	 Untersuchungen,	 die	 jene	 Ligand-Rezeptor-
Interkationen,	sowie	die	Divergenz	von	mOSM	und	hOSM	analysieren.	
	




exklusiv	 den	 hOSMR	 (A375),	 hLIFR	 (JAR),	 mOSMR	 (NIH3T3)	 und	 mLIFR	 (MH-S)	
exprimieren.	Ferner	wurden	Kurzzeit-	 sowie	Langzeitstimulationen	durchgeführt,	 in	
der	die	Phosphorylierung	des	 Signalmoleküls	 STAT3	nach	10	Minuten,	 als	 auch	die	
vermehrte	 Expression	 von	 bekannten	 Zielgenen	 (u.a.	 TIMP-1)	 nach	 24	 Stunden	
bestimmt	und	so	als	distinkte	Parameter	zur	Aktivierung	des	OSMR	genutzt	wurden.	
	
Zur	 Identifikation	 zytokinspezifischer	 Bindungsstellen	 von	 OSM	 und	 LIF	 wurden	
anfänglich	 chimäre	 hOSM/hLIF	 Varianten	 generiert,	 in	 dem	 unterschiedliche	
Bindungsstellen	 von	 hOSM	 und	 hLIF	 wechselseitig	 ausgetauscht	 wurden.	
Nachfolgende	 Stimulationsstudien	 mit	 chimären	 hOSM	 und	 hLIF	 charakterisierten	
dabei	 die	 N-terminale	 AB-Schleife,	 sowie	 die	 N-terminale	 helikale	 D-Region	 als	
hauptverantwortliche	Regionen	für	die	Aktivierung	des	OSMR,	indem	die	Aktivierung	
des	 hOSMR	 durch	 eine	 chimäre	 hLIF	 Variante	 mit	 beiden	 Regionen	 reproduziert	
werden	 konnte.	 Durch	 die	 systematische	 Generierung	 von	 Punktmutationen	 in	
beiden	Regionen	konnten	ferner	die	Aminosäurenreste	Y34,	Q38,	G39,	L45	and	P153	
als	 kritische	 Komponenten	 für	 die	 spezifische	 Aktivierung	 des	 OSMR	 durch	 OSM	
identifiziert	werden.	
	
Vergleichbare	 Methoden	 und	 Analysen	 wurden	 zur	 Charakterisierung	 der	
Bindungsspezifizität	von	mOSM	an	den	mOSMR	genutzt.	Hier	konnte	die	N-terminale	
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AB-Schleife	 und	die	 darin	 befindlichen	Aminosäurenreste	N37,	 T40	und	D42	durch	





hier	 identifizierten	 unterschiedlichen	 Bindungsspezifitäten	 von	 humanen	 und	
murinen	 OSM	 einen	 evolutionären	 Prozess	 reflektiert,	 deren	 Ursprung	 auf	 einem	
gemeinsamen		Vorläufer-Gen	begründet	ist.		
	




der	 IL-6	 Zytokinfamilie,	 d.h.	 dass	 die	 Duplikation	 des	 Vorläufergens	 zunächst	 zur	
Akquisition	 neuer	 (Aktivierung	 des	 OSMR)	 und	 anschließend	 zum	 Verlust	























































































Figure	 9:	 The	 presence	 of	 DsbC,	 a	 chaperone/disulfide	 bond	 isomerase,	 enables	
soluble	recombinant	hOSM	expression	in	E.	coli.	











Figure	17:	 Long-term	 receptor	 activation	 ability	 of	 hOSM-based	 chimeric	 cytokines	
confirms	the	importance	of	the	AB	loop	in	hOSMR	activation.	
Figure	18:	Design	of	human	LIF/OSM	chimeric	cytokines.	
Figure	 19:	 Short-term	 receptor	 activation	 ability	 of	 hLIF-based	 chimeric	 cytokines	
indicates	the	importance	of	site	III	regions	in	receptor	interaction.	
Figure	 20:	 Long-term	 receptor	 activation	 ability	 of	 hLIF-based	 chimeric	 cytokines	
confirms	the	importance	of	binding	site	III	region	for	hOSMR	interaction.	
Figure	 21:	 Short-term	 receptor	 activation	 ability	 of	 hOSM	 AB	 loop	 point	 mutants	
identifies	critical	amino	acids	for	receptor	activation.	
Figure	 22:	 Long-term	 receptor	 activation	 ability	 of	 human	 OSM	 AB	 loop	 point	
mutants	validates	critical	cytokine	residues.	
Figure	23:	Critical	AB	loop	residues	are	conserved	in	mammalians.	
Figure	 24:	 Short-term	 receptor	 activation	 ability	 of	 hOSM	N-terminal	 helix	D	point	
mutants	assesses	individual	residue	involvement.	
Figure	 25:	 Long-term	 receptor	 activation	 ability	 of	 hOSM	N-terminal	 helix	 D	 point	
mutants	confirms	critical	amino	acids	in	the	region.	
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Figure	 32:	 Short-term	 receptor	 activation	 ability	 of	mOSM	point	mutants	 suggests	
residues	determining	species	specificity	within	the	AB	loop.	




Figure	 35:	 Long-term	 receptor	 activation	 ability	 of	mOSM	 point	mutants	 confirms	
residues	determining	species	specificity	within	the	AB	loop.	






Figure	 39:	 Specific	 readout	 system	 confirms	 different	mOSM	 chimeras	 are	 able	 to	
activate	the	mLIFR.	






Figure	 43:	 Long-term	 receptor	 activation	 ability	 of	 hOSM	 point	 mutants	 confirms	
G39	as	critical	to	initiate	hOSMR	signaling.	
Figure	 44:	 Short-term	 stimulations	 with	 hOSM-based	 mutants	 indicate	 apparent	
mOSMR	activation	abilities.	
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